https://www.pharmaceutical-business-review.com/news/csl-behring-obtains-expanded-label-approval-for-berinert-in-europe-190413/ 2013-04-19T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-files-oms721-orphan-drug-application-with-fda-190413/ 2013-04-19T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/romark-begins-enrolling-patients-in-phase-3-trial-of-nt-300-influenza-drug-190413/ 2013-04-19T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/targacept-completes-patient-recruitment-for-phase-2b-schizophrenia-study-of-tc-5619-190413/ 2013-04-19T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/nanostring-licenses-liver-cancer-gene-signature-from-the-broad-institute-190413/ 2013-04-19T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/australia-new-zealand-introduce-new-process-to-evaluate-otc-medicines-190413/ 2013-04-19T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-italy-spa-deploys-cegedims-mobile-intelligence-crm-solution-220413/ 2013-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genalice-soon-to-launch-raw-dna-sequence-data-processing-software-220413/ 2013-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-treats-first-patient-in-phase-ii-study-of-myeloma-drug-220413/ 2013-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alpha-1-project-grants-150000-commission-to-expand-ipsc-lines-230413/ 2013-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-diosynth-commissions-new-billingham-cell-banking-facility-220413/ 2013-04-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cerecor-acquires-global-development-rights-to-mk-0657-from-merck-220413/ 2013-04-22T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/bausch-lomb-paragon-sign-phenylephrine-licensing-deal-in-us-220413/ 2013-04-22T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-chemport-as-additional-vascepa-active-pharmaceutical-ingredient-supplier-190413/ 2013-04-22T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-launches-dysuria-therapy-in-china-220413/ 2013-04-22T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/orchid-allecra-partner-to-develop-new-antibiotics-220413/ 2013-04-22T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-announces-manufacturing-packaging-vendors-for-lipigesic-m-230413/ 2013-04-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/study-says-dha-in-anmum-supports-growth-and-development-230413/ 2013-04-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-announces-its-express-edcplus-availability-230413/ 2013-04-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aptalis-deploys-transperfect-trial-interactive-230413/ 2013-04-22T20:03:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-astrazeneca-partner-to-develop-cancer-nanomedicine-accurin-230413/ 2013-04-23T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-genentech-extend-drug-discovery-alliance-230413/ 2013-04-23T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-warner-chilcott-oral-contraceptive-medication-230413/ 2013-04-23T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-pharmaceutical-to-open-new-australian-cgmp-biopharmaceutical-facility-in-june-230413/ 2013-04-23T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-decimmune-collaborate-to-develop-n2-pathway-blocking-antibody-230413/ 2013-04-23T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-phyto-nutricare-to-develop-nutraceutical-products-230413/ 2013-04-23T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-carry-out-phase-ii-hepatitis-c-trial-under-deal-with-bristol-myers-230413/ 2013-04-23T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-unveils-new-bioprocessing-mixing-system-240413/ 2013-04-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/activaero-university-of-giessen-extend-pulmonary-hypertension-collaboration-240413/ 2013-04-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-xenon-announce-fda-orphan-drug-designation-for-xen402-analgesic-240413/ 2013-04-24T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/alitair-benzonatate-formulation-now-eligible-for-rx-to-otc-switch-240413/ 2013-04-24T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/bionomics-commences-bnc10-manufacturing-activities-240413/ 2013-04-24T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/kymab-and-novo-nordisk-sign-kymouse-antibody-discovery-deal-240413/ 2013-04-24T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sareum-sri-to-jointly-develop-autoimmune-inflammatory-disease-therapeutics-240413/ 2013-04-24T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/prothena-doses-first-patient-in-neod001-phase-i-al-amyloidosis-study-240413/ 2013-04-24T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ebrd-funds-piramida-to-expand-production-240413/ 2013-04-24T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bd-rxs-metoclopramide-injection-usp-240413/ 2013-04-24T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bruker-university-of-victoria-collaborate-to-develop-high-throughput-assays-240413/ 2013-04-24T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-funds-canadian-life-sciences-research-240413/ 2013-04-24T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sygnis-wins-us-patent-for-dna-amplification-tool-240413/ 2013-04-24T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/intelsius-unveil-sreusable-courier-transit-case-250413/ 2013-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-signs-new-service-agreement-with-ono-250413/ 2013-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-sell-lucozade-ribena-soft-drink-brands-250413/ 2013-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-to-support-sms-ic-250413/ 2013-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/avalon-gsk-partner-to-create-10-life-sciences-companies-in-san-diego-250413/ 2013-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-q1-profit-declined-250413/ 2013-04-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-government-files-civil-fraud-lawsuit-accusing-novartis-of-healthcare-scam-250413/ 2013-04-25T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-notice-of-allowance-for-gw-pharmaceuticals-sativex-formulation-spray-device-250413/ 2013-04-25T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-research-announces-launch-of-pliaglis-in-europe-250413/ 2013-04-25T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-establishes-global-specialty-medicines-group-250413/ 2013-04-25T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-temporarily-close-niacin-production-plant-in-visp-250413/ 2013-04-25T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biooutsource-opens-new-cambridge-facility-for-bioanalytical-biosafety-services-250413/ 2013-04-25T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-enrolls-first-patient-in-two-pivotal-phase-3-trials-of-nimotuzumab-250413/ 2013-04-25T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-sanofis-6-in-1-pediatric-vaccine-250413/ 2013-04-25T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-initiates-glpg0974-phase-2a-ulcerative-colitis-study-250413/ 2013-04-25T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-submit-anoro-ellipta-regulatory-application-in-japan-250413/ 2013-04-25T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-kalobios-announce-fda-fast-track-designation-for-kb001a-250413/ 2013-04-25T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-introduces-aegis5-14-film-for-cell-culture-bioprocessing-applications-250413/ 2013-04-25T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/star-scientific-receives-hfl-registration-approval-for-anatabloc-dietary-supplement-260413/ 2013-04-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perosphere-daiichi-sankyo-sign-per977-clinical-trial-agreement-260413/ 2013-04-26T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-resolves-intuniv-patent-litigation-with-shire-260413/ 2013-04-26T01:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/anlit-launches-new-yomi-magnesium-for-children-260413/ 2013-04-26T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/paragon-unveils-nextdocs-migration-solution-260413/ 2013-04-26T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-anticipates-interruption-in-increlex-supply-due-to-manufacturing-issues-260413/ 2013-04-26T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-makes-selincro-available-in-norway-finland-poland-baltic-markets-260413/ 2013-04-26T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ferndale-healthcare-launches-heliocare-for-skin-care-260413/ 2013-04-26T09:30:00+00:00 https://www.pharmaceutical-business-review.com/news/porkka-launches-new-scientific-product-range-290413/ 2013-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/covaris-introduces-new-afa-based-processing-system-290413/ 2013-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cloud-computing-helps-pharmaceutical-industry-optimize-dna-sequencing-and-trials-data-study-290413/ 2013-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/direct-digital-launches-new-joint-relief-formulation-290413/ 2013-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/crown-marketing-to-introduce-nutraceuticals-products-line-290413/ 2013-04-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sectra-enters-into-healthcare-it-distribution-deal-with-answer-medical-in-puerto-rico-290513/ 2013-04-29T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-3-study-of-prevenar-13-meets-primary-secondary-objectives-290413/ 2013-04-29T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-aurobindo-cefadroxil-antibiotic-290413/ 2013-04-29T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-dymista-now-available-on-prescription-in-uk-290413/ 2013-04-29T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-announces-positive-chmp-opinion-for-conditional-approval-of-erivedge-290413/ 2013-04-29T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-commences-phase-2-trial-of-mor208-leukemia-drug-290413/ 2013-04-29T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/optimer-dificid-wins-approval-from-australian-regulatory-body-290413/ 2013-04-29T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/hemp-inks-agreement-for-herbagenix-300413/ 2013-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-seeks-eu-approval-for-umeclidinium-monotherapy-for-copd-patients-300413/ 2013-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/second-lawsuit-filed-against-actos-diabetes-drug-manufacturer-in-us-300413/ 2013-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-warns-people-against-anti-seizure-drug-potiga-300413/ 2013-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/apotex-recalls-piperacillin-tazobactam-for-injection-usp-405-grams-300413/ 2013-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-pfizer-to-jointly-develop-investigational-type-2-diabetes-drug-300413/ 2013-04-30T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-impax-terminate-ipx066-development-deal-300413/ 2013-04-30T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-signs-phytofare-distribution-deal-with-nutragenesis-300413/ 2013-04-30T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-completes-patient-enrollment-in-phase-i-trial-of-breast-cancer-agent-300413/ 2013-04-30T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-wins-milestone-payment-worth-25m-from-novartis-300413/ 2013-04-30T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-to-expand-compound-management-services-to-east-coast-of-us-300413/ 2013-04-30T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-coldstream-to-develop-cytotoxic-antibody-drug-conjugates-300413/ 2013-04-30T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-obtains-manufacturing-approval-for-quinapril-tablets-010513/ 2013-04-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-seeks-fda-approval-for-copd-monotherapy-010513/ 2013-04-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thorne-research-enters-into-jv-with-youcare-pharmaceutical-010513/ 2013-04-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-teva-womens-contraceptive-medication-for-over-the-counter-sale-010513/ 2013-05-01T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/dana-farbers-belfer-institute-for-applied-cancer-science-evotec-sign-oncology-research-deal-010513/ 2013-05-01T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-q1-net-income-increased-010513/ 2013-05-01T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/auris-selects-medidata-clinical-cloud-for-tinnitus-research-010513/ 2013-05-01T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/emisphere-novo-nordisk-amend-oral-glp-1-development-license-agreement-010513/ 2013-05-01T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ecr-pharmaceuticals-re-launches-zolpimist-oral-spray-dexpak-taperpaks-010513/ 2013-05-01T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-acquires-heron-group-010513/ 2013-05-01T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/cipher-tecnofarma-sign-supply-agreement-for-extended-release-tramadol-010513/ 2013-05-01T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cara-maruishi-sign-licensing-deal-for-analgesic-drug-010513/ 2013-05-01T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-announces-positive-top-line-results-from-phase-ii-cll-study-of-ofatumumab-020513/ 2013-05-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-takes-over-global-rights-for-valeants-metronidazole-13-vaginal-gel-antibiotic-020513/ 2013-05-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oncogenex-to-commence-phase-2-rainier-trial-assessing-pancreatic-cancer-drug-020513/ 2013-05-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-almirall-report-positive-results-from-acliformcopd-phase-iii-study-020513/ 2013-05-02T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/batavia-uva-sign-step-technology-licensing-deal-020513/ 2013-05-02T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/prasco-to-distribute-wellspring-phenoxybenzamine-hydrochloride-capsules-in-us-020513/ 2013-05-02T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/cellhealth-unveils-new-cell-health-formula-020513/ 2013-05-02T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/mount-sinai-chooses-sapios-exemplar-lims-for-genomics-core-facility-020513/ 2013-05-02T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/xymogen-recalls-dietary-supplement-artriphen-020513/ 2013-05-02T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-launches-silenor-in-canada-020513/ 2013-05-02T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/vertellus-upgrades-belgium-facility-to-manufacture-niacin-for-pharmaceutical-use-030513/ 2013-05-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pbs-biotech-to-distribute-scrums-single-use-bioreactor-technology-in-japan-030513/ 2013-05-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/co-diagnostics-to-acquire-certain-technologies-from-dna-logix-030513/ 2013-05-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hyperion-wins-orphan-drug-exclusivity-for-ravicti-liquid-030513/ 2013-05-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-raptors-procysbi-delayed-release-capsules-030513/ 2013-05-03T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-biopharma-reports-negotiations-with-suppliers-for-adva-27a-breast-cancer-drug-candidate-030513/ 2013-05-03T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/abide-merck-collaborate-on-development-of-new-therapies-for-metabolic-diseases-030513/ 2013-05-03T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/allegro-senju-sign-licensing-deal-to-develop-integrin-peptide-therapy-against-vascular-eye-diseases-030513/ 2013-05-03T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/chemrar-signs-scouting-pharma-partnering-agreement-with-sanofi-030513/ 2013-05-03T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-pharmaceuticals-initiates-phase-iii-trials-of-elobixibat-030513/ 2013-05-03T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-launches-lymphoseek-injection-in-us-030513/ 2013-05-03T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/diamedica-announces-commencement-of-phase-iii-clinical-trial-060513/ 2013-05-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-inks-license-agreement-with-pharmascience-foranti-cancer-program-060513/ 2013-05-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/martindale-pharma-launches-prenoxad-injection-in-uk-060513/ 2013-05-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-obtains-fda-approval-for-liptruzet-tablets-060513/ 2013-05-06T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ambrx-bristol-myers-collaborate-on-discovery-of-next-generation-antibody-drug-conjugates-060513/ 2013-05-06T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/itonis-oasis-health-sign-manufacturing-deal-for-anti-nausea-spray-products-060513/ 2013-05-06T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-completes-patient-enrollment-in-phase-3-bph-study-of-nx-1207-060513/ 2013-05-06T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-reports-decreased-q1-net-income-060513/ 2013-05-06T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/kinex-zenith-enter-into-collaborative-licensing-agreement-070513/ 2013-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-outcome-updates-on-rd-collaboration-projects-070513/ 2013-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dvs-sciences-introduces-cytof-2-mass-cytometer-maxpar-panel-kits-060513/ 2013-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/penn-pharmas-new-facility-produces-first-batch-of-coated-tablets-070513/ 2013-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tricast-introduces-accucast-070513/ 2013-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-pharmaceuticals-announces-positive-results-from-exparel-studies-070513/ 2013-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-reaches-milestone-in-ophthalmology-program-with-novartis-070513/ 2013-05-07T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-announces-funding-from-wellcome-trust-070513/ 2013-05-07T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-celgene-to-develop-deuterium-modified-compounds-070513/ 2013-05-07T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cml-inflamax-to-offer-clinical-research-and-bioanalytical-services-080513/ 2013-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-receives-fast-track-status-for-antibiotic-candidate-080513/ 2013-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-to-open-new-rd-center-in-uk-080513/ 2013-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-launches-new-purchasing-website-for-its-viagra-tablets-080513/ 2013-05-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-commences-pre-clinical-development-of-allergic-asthma-candidate-080513/ 2013-05-08T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-drais-partner-to-develop-nocturia-compound-through-tacurion-080513/ 2013-05-08T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-invests-in-kalundborg-plant-for-semaglutide-production-080513/ 2013-05-08T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-pharmaceuticals-q1-net-income-increases-080513/ 2013-05-08T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/italy-grants-commercialization-approval-for-gw-pharmaceuticals-sativex-080513/ 2013-05-08T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-iluvien-available-in-germany-080513/ 2013-05-08T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/mapi-pharma-receives-us-patent-for-multiple-sclerosis-treatment-080513/ 2013-05-08T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-to-acquire-remaining-stake-inkspc-jv-080513/ 2013-05-08T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/corgenix-medical-receives-ce-mark-for-relasv-antigen-rapid-test-for-lassa-fever-090513/ 2013-05-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pazoo-announces-availability-of-maxline-products-in-nutrition-zone-stores-090513/ 2013-05-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/trilink-signs-tina-modified-oligonucleotide-licensing-contract-with-quantibact-090513/ 2013-05-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-announces-new-online-system-to-share-patient-level-data-with-researchers-090513/ 2013-05-08T19:32:00+00:00 https://www.pharmaceutical-business-review.com/news/dong-sung-to-market-biogaia-products-in-south-korea-090513/ 2013-05-09T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-selects-accenture-for-standardization-of-global-it-operations-090513/ 2013-05-09T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-commercialize-alexza-adasuve-loxapine-inhalation-powder-in-us-090513/ 2013-05-09T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/greenphire-opens-new-london-office-090513/ 2013-05-09T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cornerstone-to-take-over-marketing-rights-to-pertzye-in-us-from-digestive-care-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/warner-chilcott-announces-fda-approval-of-new-oral-contraceptive-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/orgenesis-atmi-sign-process-development-agreement-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/usfda-expands-indication-of-medicines-companys-recothrom-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prometheus-enrolls-patients-for-proclivity-01-study-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-announces-distribution-agreement-with-natural-products-for-phytofare-catechin-extract-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/unigene-nordic-sign-equity-transfer-exclusive-license-agreement-for-metabolic-peptide-analogs-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/american-pacific-reports-increased-q2-net-income-100513/ 2013-05-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/celsus-reports-positive-interim-results-from-first-cohort-of-mrx-6-phase-ii-trial-100513/ 2013-05-09T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-introduces-new-intelligence-capabilities-for-tibco-spotfire-platform-100513/ 2013-05-10T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptive-signs-biomarker-discovery-partnership-in-oncology-with-bristol-myers-100513/ 2013-05-10T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-merck-biologics-license-application-for-allergy-immunotherapy-tablet-100513/ 2013-05-10T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/onq-research-selects-merges-eclinical-os-solution-for-electronic-data-capture-100513/ 2013-05-10T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-save-the-children-partner-to-save-lives-of-million-children-across-world-100513/ 2013-05-10T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-consumer-signs-brandsswap-deal-with-gsk-pharmaceuticals-100513/ 2013-05-10T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/nimbus-shire-enter-into-co-development-agreement-for-lysosomal-storage-disorders-100513/ 2013-05-10T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/beamonstar-recalls-sexvoltz-velextra-amerect-capsules-100513/ 2013-05-10T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-supply-cervical-cancer-vaccine-to-support-gavi-project-100513/ 2013-05-10T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/onconova-completes-patient-enrollment-in-phase-3-study-of-cancer-drug-100513/ 2013-05-10T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharmaceuticals-earns-35m-in-milestone-payment-from-biogen-idec-130513/ 2013-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/als-etf-denovo-partner-for-amyotrophic-lateral-sclerosis-treatment-130513/ 2013-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-elan-enter-into-royalty-participation-agreement-130513/ 2013-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/apotex-recalls-21-lots-of-piperacillin-tazobactam-for-injection-in-us-130513/ 2013-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/india-based-protech-biopharma-eyes-kazakhstan-market-130513/ 2013-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-announce-fda-approval-of-copd-therapy-130513/ 2013-05-13T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-announces-approval-of-erivedge-anti-cancer-drug-in-australia-130513/ 2013-05-13T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-enzastaurin-phase-iii-study-fails-to-meet-primary-endpoint-130513/ 2013-05-13T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-ilaris-to-treat-active-systemic-juvenile-idiopathic-arthritis-130513/ 2013-05-13T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-to-commercialize-glaxosmithkline-antibiotic-product-line-in-hong-kong-130513/ 2013-05-13T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-lx4211-enters-into-placebo-controlled-portion-of-phase-2-type-1-diabetes-trial-130513/ 2013-05-13T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/marine-scotland-rejects-gsk-tidal-turbine-proposal-for-montrose-site-140513/ 2013-05-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-zhejiang-beta-partner-to-commercialize-vectibix-in-china-140513/ 2013-05-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-begins-phase-1-cancer-trial-mrx34-140513/ 2013-05-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-begins-dosing-patients-in-phase-2-lymphoma-drug-study-140513/ 2013-05-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-to-pay-500m-fine-to-settle-drug-safety-charges-in-us-140513/ 2013-05-14T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisourcebergen-completes-divestiture-of-andersonbrecon-140513/ 2013-05-14T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-igdrasol-announce-european-distribution-rights-to-samyang-cynviloq-140513/ 2013-05-14T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/beijing-keyuan-to-sell-biogaia-products-in-china-150513/ 2013-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cempra-toyama-chemical-sign-exclusive-license-development-agreement-for-solithromycin-150513/ 2013-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/research-solutions-introduces-new-saas-solution-for-pharma-companies-150513/ 2013-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-announce-patient-enrolment-in-sarilumab-phase-3-rheumatoid-arthritis-trials-150513/ 2013-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-enters-into-antibody-development-agreement-with-ruiyi-150513/ 2013-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actinium-receives-notice-of-patent-allowance-for-cancer-treatment-with-alpha-emitting-isotopes-140513/ 2013-05-15T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/india-develops-new-low-cost-vaccine-against-diarrhea-virus-150513/ 2013-05-15T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-research-expands-manufacturing-capabilities-to-support-pharmaceutical-development-150513/ 2013-05-15T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-alvine-to-jointly-develop-new-therapy-for-celiac-disease-150513/ 2013-05-15T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/rib-x-commences-phase-3-acute-bacterial-skin-and-skin-structure-infections-trial-150513/ 2013-05-15T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-obtains-fda-tentative-approval-for-guanfacine-hydrochloride-anda-150513/ 2013-05-15T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-commences-omp-59r5-phase-1b2-small-cell-lung-cancer-trial-150413/ 2013-05-15T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/hitachi-to-market-nanosphere-products-in-japan-160513/ 2013-05-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/definiens-launches-software-to-improve-productivity-in-tissue-based-research-160513/ 2013-05-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-algetas-xofigo-injection-for-castration-resistant-prostate-cancer-160513/ 2013-05-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sygnis-pharma-licenses-new-amplification-buffer-to-qiagen-160513/ 2013-05-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-commences-phase-iii-trial-of-stivarga-tablets-to-treat-hepatocellular-carcinoma-160513/ 2013-05-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-quintiles-sign-five-year-clinical-development-agreement-160513/ 2013-05-16T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/nordion-navidea-sign-contract-manufacturing-agreement-160513/ 2013-05-16T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-zolmitriptan-anda-160513/ 2013-05-16T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-begins-phase-1-crohns-disease-study-with-sgx203-160513/ 2013-05-16T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/echevarne-to-distribute-nateras-prenatal-screening-test-in-spain-160513/ 2013-05-16T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-astellas-announce-fda-approval-of-tarceva-tablets-160513/ 2013-05-16T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-research-wins-us-patent-for-wf10-drug-candidate-160513/ 2013-05-16T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/usfda-approves-xofigo-as-castration-resistant-prostate-cancer-therapy-160513/ 2013-05-16T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-announces-fda-approval-of-simponi-ulcerative-colitis-therapy-160513/ 2013-05-16T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bioduro-opens-laboratory-in-china-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-expands-onesource-laboratory-consulting-services-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alethia-gains-us-patent-for-cancer-treatment-methods-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-government-awards-antibody-development-contract-to-anaptysbio-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-to-acquire-steigerwald-arzneimittelwerk-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-oramed-ind-application-for-oral-insulin-capsule-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-version-of-abbvie-tricor-tablets-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/taigen-submits-nda-for-nemonoxacin-with-tfda-cfda-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-afatinib-nintedanib-found-to-improve-progression-free-survival-in-advanced-nsclc-patients-170513/ 2013-05-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-ibm-collaborate-on-super-computer-project-to-improve-epilepsy-care-170513/ 2013-05-17T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-vifor-sign-distribution-deal-for-netupitant-palonosetron-fixed-dose-combination-170513/ 2013-05-17T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-harvard-to-jointly-develop-new-class-of-antibacterials-170513/ 2013-05-17T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/trillium-therapeutics-completes-dosing-in-phase-i-study-of-tti-1612-170513/ 2013-05-17T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-secures-bbsrc-programme-with-ucl-170513/ 2013-05-17T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sciclone-zensun-enters-into-service-agreement-for-neucardin-in-china-170513/ 2013-05-17T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/nw-bio-phase-iii-trial-with-dcvax-l-for-brain-cancer-commences-at-kings-college-hospital-170513/ 2013-05-17T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-illumina-collaborate-to-launch-genomics-data-app-200513/ 2013-05-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-dyadic-enter-into-non-exclusive-research-license-agreement-200513/ 2013-05-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-galapagos-extend-glpg0634-agreement-to-include-crohns-disease-200513/ 2013-05-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-reports-positive-results-from-phase-3-haemophilia-b-study-of-n9-gp-200513/ 2013-05-20T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ruiyi-genor-sign-ryi-008-development-deal-in-china-200513/ 2013-05-20T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/r-tech-begins-enrolling-patients-in-phase-iii-severe-dry-eye-study-200513/ 2013-05-20T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/dbv-stallergenes-sign-strategic-research-partnership-targeting-respiratory-allergies-200513/ 2013-05-20T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-obtains-us-patent-covering-use-of-interleukin-13-receptor-alpha-2-protein-200513/ 2013-05-20T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-enrolls-50-patients-in-phase-i-knee-osteoarthritis-trial-200513/ 2013-05-20T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-introduces-authorized-generic-of-zomig-in-us-200513/ 2013-05-20T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/invite-health-unveils-food-based-dietary-supplement-powder-210513/ 2013-05-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-to-acquire-warner-chilcott-210513/ 2013-05-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-purchases-xellia-pharmaceuticals-for-700m-210513/ 2013-05-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-recalls-methotrexate-sodium-injectable-vials-210513/ 2013-05-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-discontinues-phase-3-non-hodgkin-lymphoma-study-of-inotuzumab-ozogamicin-210513/ 2013-05-21T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-obtains-additional-us-patent-for-ampyra-210513/ 2013-05-21T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/steribeam-announces-results-of-6-logs-sterilization-of-b-pumilus-spores-on-standard-equipment-210513/ 2013-05-21T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-begins-atrasentan-phase-3-diabetic-nephropathy-study-210513/ 2013-05-21T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-launches-new-small-benchtop-centrifuge-220513/ 2013-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/liquidia-extends-collaboration-with-path-to-develop-pneumococcal-vaccine-220513/ 2013-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rlc-packaging-expands-poznan-pharmaceutical-packaging-center-220513/ 2013-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/grifols-aradigm-sign-licensing-deal-for-inhaled-ciprofloxacin-formulations-220513/ 2013-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-shut-down-tablet-packaging-facility-in-melbourne-220513/ 2013-05-22T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-announce-positive-phase-2a-study-results-of-asthma-drug-220513/ 2013-05-22T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-inaugurates-international-headquarters-in-laval-220513/ 2013-05-22T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/avion-unveils-prenate-chewable-prenatal-vitamin-220513/ 2013-05-22T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/us-organic-group-develops-over-the-counter-organic-anti-itch-ointment-220513/ 2013-05-22T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/jennerex-completes-enrollment-in-phase-2b-trial-of-liver-cancer-drug-220513/ 2013-05-22T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/partech-kennedy-krieger-institute-collaborate-to-develop-software-to-identify-asd-230513/ 2013-05-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-pakistan-to-wind-up-operations-230513/ 2013-05-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-receives-warning-letter-from-fda-over-cgmp-failures-230513/ 2013-05-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-university-of-rouen-bti-collaborate-to-analyze-biologics-and-vaccines-230513/ 2013-05-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-confirms-lipigesic-m-migrane-treatment-as-robust-efficacy-230513/ 2013-05-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-us-hhs-team-up-to-develop-drugs-against-antibiotic-resistance-and-bioterrorism-230513/ 2013-05-23T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-seeks-fda-approval-for-plegridy-in-multiple-sclerosis-therapy-230513/ 2013-05-23T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/corgenix-partners-with-eli-lilly-to-develop-diagnostic-technology-230513/ 2013-05-23T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-entry-of-r-tech-ophthalmic-solution-into-phase-iii-trials-230513/ 2013-05-23T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-thermovax-technology-receives-us-patent-230513/ 2013-05-23T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/campus-biotech-buys-merck-geneva-headquarters-230513/ 2013-05-23T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/duchesnay-introduces-diclegis-in-us-market-230513/ 2013-05-23T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bellwyck-opens-new-facility-for-us-clinical-services-activities-240513/ 2013-05-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/netherlands-meb-grants-marketing-authorization-for-astellas-vesomni-240513/ 2013-05-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-begins-patient-dosing-in-phase-2a-trial-of-anti-cancer-drug-240513/ 2013-05-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-plans-to-submit-over-10-new-drugs-for-regulatory-approval-by-2017-240513/ 2013-05-24T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-omeros-ind-for-oms824-in-huntingtons-disease-240513/ 2013-05-24T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/servier-miragen-to-add-third-cardiovascular-target-under-strategic-alliance-240513/ 2013-05-24T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/medvantx-completes-expansion-of-home-delivery-platform-240513/ 2013-05-24T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/howard-university-and-tni-biotech-sign-drug-development-deal-240513/ 2013-05-24T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/china-state-and-food-administration-grants-gmp-certificate-to-sinovac-beijing-240513/ 2013-05-24T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-snda-of-abraxane-obtains-fda-priority-review-status-240513/ 2013-05-24T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/umecrine-starts-dosing-in-phase-iii-study-of-premenstrual-dysphoric-disorder-drug-240513/ 2013-05-24T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/nordion-agrees-to-sell-targeted-therapies-business-to-btg-240513/ 2013-05-24T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-completes-patient-enrollment-in-phase-2-breast-cancer-study-240513/ 2013-05-24T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/makers-of-calpol-introduce-new-app-to-support-mothers-in-caring-poorly-child-270513/ 2013-05-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-launch-new-liraglutide-obesity-drug-in-us-next-year-270513/ 2013-05-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sangamo-receives-grant-to-develop-zfp-therapeutic-for-beta-thalassemia-270513/ 2013-05-26T20:37:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-submits-marketing-application-of-enzalutamide-in-japan-270513/ 2013-05-27T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-seeks-manufacturing-marketing-approval-for-ta-7284-in-japan-270513/ 2013-05-27T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-opts-datameer-for-data-discovery-270513/ 2013-05-27T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/amjay-software-introduces-mobile-pharmacy-application-in-canada-270513/ 2013-05-27T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fuse-science-adds-powerfuse-electrofuse-products-to-portfolio-in-europe-270513/ 2013-05-27T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-completes-enrolling-onychomycosis-patients-in-phase-ii-trial-of-mob-015-270513/ 2013-05-27T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-voluntarily-recalls-one-lot-of-magnesium-sulfate-injection-usp-270513/ 2013-05-27T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-generics-recalls-three-drugs-from-us-270513/ 2013-05-27T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/india-agrees-to-set-up-third-world-pharma-trade-centre-at-hyderabad-270513/ 2013-05-27T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/new-cardioviva-probiotic-supplement-available-across-canada-and-us-280513/ 2013-05-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/orderviacom-launches-private-label-supplements-280513/ 2013-05-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/goose-introduces-quality-management-technology-for-pharma-industry-280513/ 2013-05-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alcon-introduces-thrombogenics-jetrea-in-denmark-sweden-280513/ 2013-05-28T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-presents-results-from-pharmacokinetic-pharmacodynamic-study-on-sitavig-280513/ 2013-05-28T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/schott-north-america-introduces-10ml-duran-laboratory-bottle-280513/ 2013-05-28T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-take-over-omthera-pharmaceuticals-280513/ 2013-05-28T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/basileas-isavuconazole-obtains-fda-orphan-drug-status-280513/ 2013-05-28T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharma-plans-to-purchase-bausch-lomb-for-87bn-280513/ 2013-05-28T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/dcprime-phase-iiia-study-of-dendritic-cancer-vaccine-meet-endpoints-280513/ 2013-05-28T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/hamilton-robotics-illumina-team-up-to-automate-sample-preparation-of-ngs-workflow-290513/ 2013-05-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rusnano-domain-associates-agree-to-set-up-pharma-facility-in-russia-290513/ 2013-05-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-gilead-sciences-stribild-for-hiv-1-treatment-290513/ 2013-05-29T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/veeva-systems-vault-promomats-and-crm-selected-by-a-global-pharmaceutical-company-290513/ 2013-05-29T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-astellas-partner-to-offer-new-medicines-to-patients-in-japan-290513/ 2013-05-29T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/grunenthal-purdue-sign-licensing-agreement-for-certain-intellectual-property-rights-290513/ 2013-05-29T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaroth-signs-sucanon-distribution-deal-with-marcas-de-renombre-in-mexico-290513/ 2013-05-29T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-launches-new-seqcap-ez-pure-capture-bead-kit-290513/ 2013-05-29T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/us-issues-additional-patent-allowance-for-nupathes-migraine-therapy-290513/ 2013-05-29T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/trino-therapeutics-secures-funding-to-advance-ulcerative-colitis-drug-290513/ 2013-05-29T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cempra-to-develop-antibiotic-solithromycin-for-pediatric-use-and-biodefense-290513/ 2013-05-29T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-completes-phase-iia-study-of-elsiglutide-for-prevention-of-chemotherapy-induced-diarrhea-290513/ 2013-05-29T08:59:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-licenses-amp-rx-protein-design-technology-from-eleven-290513/ 2013-05-29T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/luminex-emd-millipore-extend-supply-and-distribution-agreement-to-develop-protein-assays-290513/ 2013-05-29T09:13:00+00:00 https://www.pharmaceutical-business-review.com/news/ineos-barex-to-acquire-polyacrylonitriles-business-from-mitsui-chemicals-300513/ 2013-05-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kevelt-to-produce-cancer-drug-candidate-virexxa-300513/ 2013-05-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-gsks-tafinlar-mekinist-for-metastatic-melanoma-300513/ 2013-05-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-acquires-okairos-for-eur250m-to-boost-vaccines-business-300513/ 2013-05-30T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/upm-pharmaceuticals-to-buy-pfizers-tennessee-manufacturing-facility-300513/ 2013-05-30T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-genmab-announce-positive-results-from-phase-iii-study-of-arzerra-300513/ 2013-05-30T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-acquires-worldwide-intellectual-property-rights-to-olons-amorphous-rifaximin-300513/ 2013-05-30T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-cti-collaborates-with-ucsf-to-boost-drug-discovery-capabilities-300513/ 2013-05-30T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/scripsamerica-signs-rapimed-manufacturing-supply-deal-with-capricorn-pharma-300513/ 2013-05-30T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/scynexis-gains-global-rights-to-antifungal-compound-from-merck-300513/ 2013-05-30T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/biotage-rolls-out-completely-integrated-mass-directed-flash-system-310513/ 2013-05-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hunan-china-sun-to-establish-intravenous-iv-infusion-solutions-facility-in-pakistan-310513/ 2013-05-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prometheus-to-start-phase-iv-multi-center-study-of-proleukin-310513/ 2013-05-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ageforce-unveils-weight-loss-fat-burner-patch-310513/ 2013-05-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-signs-technology-evaluation-agreement-with-undisclosed-pharma-firm-310513/ 2013-05-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-supplemental-new-drug-application-for-tevas-copaxone-40mg1ml-310513/ 2013-05-31T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-wins-us-patent-for-anti-s1p-antibody-to-treat-ocular-conditions-310513/ 2013-05-31T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/tomi-to-open-new-facility-for-binary-ionization-technology-equipment-in-san-diego-310513/ 2013-05-31T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/cempra-announces-allowance-of-us-patent-to-taksta-loading-dose-formulation-310513/ 2013-05-31T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/office-of-the-chief-scientist-israel-awards-grant-to-oramed-pharmaceuticals-310513/ 2013-05-31T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alethia-signs-research-deal-with-ibc-generium-for-emt-inhibitor-310513/ 2013-05-31T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-creon-delayed-release-capsules-available-at-higher-dose-in-us-310513/ 2013-05-31T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/crown-marketing-seeks-us-patent-for-novel-diet-supplement-310513/ 2013-05-31T09:22:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerions-marketing-authorization-for-lojuxta-wins-positive-chmp-opinion-in-europe-310513/ 2013-05-31T09:23:00+00:00 https://www.pharmaceutical-business-review.com/news/chimerix-extends-cmx001-development-contract-with-barda-to-treat-smallpox-030613/ 2013-06-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-launches-niagen-030613/ 2013-06-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genevac-rolls-out-new-automated-evaporator-rocket-4d-030613/ 2013-06-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-receives-fda-warning-letter-for-drug-contamination-at-indian-facility-030613/ 2013-06-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cryoxtract-frozen-sample-aliquotting-technology-wins-us-patent-030613/ 2013-06-02T22:12:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-votrient-meets-primary-objective-in-phase-iii-ovarian-cancer-trial-030613/ 2013-06-03T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-seeks-approval-for-extended-indication-of-topotecin-in-japan-030613/ 2013-06-03T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/mannkind-completes-phase-3-study-of-type-1-diabetes-candidate-030613/ 2013-06-03T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/oncothyreon-array-to-jointly-develop-breast-cancer-drug-030613/ 2013-06-03T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-introduces-denotas-chewable-combination-tablets-in-japan-030613/ 2013-06-03T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/celgenes-oral-anti-cancer-therapy-receives-positive-chmp-opinion-030613/ 2013-06-03T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-may-acquire-swedens-meda-030613/ 2013-06-03T09:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-terminate-investigational-program-with-iniparib-otamixaban-040613/ 2013-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neuroderm-receives-funding-for-phase-2-clinical-trial-of-parkinsons-disease-drug-040613/ 2013-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glycanova-introduces-ganodex-skin-cream-treatment-for-eczema-and-psoriasis-040613/ 2013-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-recalls-32-million-boxes-of-cilest-birth-control-pill-040613/ 2013-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicomm-to-provide-trialone-suite-of-applications-for-an-undisclosed-company-040613/ 2013-06-03T20:23:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-to-fine-nine-drug-firms-for-blocking-generic-drugs-entry-into-market-040613/ 2013-06-04T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-tykerbtyverb-phase-iii-gastric-cancer-study-fails-to-meet-primary-endpoint-040513/ 2013-06-04T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-fujifilm-terminate-jv-plans-for-generic-drugs-business-in-japan-040613/ 2013-06-04T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisourcebergen-sells-canadian-pharmaceutical-distribution-business-to-kohl-frisch-040613/ 2013-06-04T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-to-develop-manufacturing-process-for-true-human-therapeutic-antibody-040613/ 2013-06-04T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/effrx-grants-ahn-gook-pharma-rights-to-distribute-binosto-in-south-korea-040613/ 2013-06-04T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-medivation-announce-health-canada-approval-of-xtandi-040613/ 2013-06-04T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-develop-and-commercialize-morphosys-hucal-derived-antibody-050613/ 2013-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-advances-new-chemical-entity-into-preclinical-development-050613/ 2013-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aqua-takes-over-us-rights-to-verdeso-foam-from-stiefel-050613/ 2013-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/opgen-partners-with-applied-maths-for-bioinformatics-analysis-software-050613/ 2013-06-04T21:28:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-zeria-to-launch-functional-dyspepsia-medication-in-japan-050613/ 2013-06-05T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-biotechnology-signs-biothrax-process-development-sub-contract-with-emergent-050613/ 2013-06-05T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharmaceuticals-generic-depo-testosterone-injection-wins-fda-approval-050613/ 2013-06-05T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-introduces-new-chemical-structure-drawing-visualization-apps-050613/ 2013-06-05T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/tunitas-wins-sbir-phase-ii-grant-to-progress-asthma-program-050613/ 2013-06-05T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/usfda-grants-priority-review-status-for-bristol-astrazeneca-lipodystrophy-medication-050613/ 2013-06-05T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/dainippon-sumitomo-pharma-builds-new-chemistry-research-center-050613/ 2013-06-05T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/renaissance-to-manufacture-market-and-sell-nine-gsk-products-050613/ 2013-06-05T09:22:00+00:00 https://www.pharmaceutical-business-review.com/news/second-genome-signs-microbiome-drug-discovery-deal-with-janssen-060613/ 2013-06-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-opens-california-innovation-center-060613/ 2013-06-06T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-signs-enzalutamide-distribution-deal-with-tecnofarma-in-latin-america-060613/ 2013-06-06T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-celgenes-snda-for-mantle-cell-lymphoma-drug-candidate-060613/ 2013-06-06T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/proteostasis-receives-preclinical-research-funding-for-parkinsons-disease-060613/ 2013-06-06T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sotax-buys-dr-schleuniger-pharmatron-060613/ 2013-06-06T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/diaxonhit-partners-with-xdx-to-market-allomap-in-europe-060613/ 2013-06-06T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-plans-to-invest-eur10bn-in-asia-pacific-by-2020-060613/ 2013-06-06T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/perfecseal-introduces-new-high-barrier-pvc-free-blister-forming-web-060613/ 2013-06-06T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/riverside-partners-completes-investment-in-bioagilytix-labs-060613/ 2013-06-06T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/vestiq-to-offer-magbid-er-magnesium-dietary-supplement-060613/ 2013-06-06T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-intends-to-slash-110-jobs-070613/ 2013-06-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/affirm-xl-dietary-supplement-re-launched-in-us-070613/ 2013-06-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rxvantage-acquires-repaccess-online-appointment-scheduling-service-070613/ 2013-06-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biosyent-pharma-unveils-feramax-oral-iron-supplement-in-canada-070613/ 2013-06-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clinverse-launches-clinspend-to-comply-with-sunshine-act-070613/ 2013-06-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-begins-enrolling-acute-myeloid-leukaemia-patients-in-phase-2-trial-of-bl-8040-070613/ 2013-06-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genoa-mcmaster-university-reveal-findings-of-gp-101-in-pulmonary-fibrosis-treatment-070613/ 2013-06-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alliance-pharmaceuticals-acquires-rights-to-novartis-syntometrine-obstetric-drug-070613/ 2013-06-07T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/nextpharma-to-launch-mitsubishi-pharmas-bindren-in-europe-070613/ 2013-06-07T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-to-build-new-cgmp-biopharmaceuticals-facility-in-china-070613/ 2013-06-07T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-genspera-for-activation-of-peptide-prodrugs-by-hk2-070613/ 2013-06-07T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fluxion-biosciences-delivers-initial-shipments-of-isoflux-system-070613/ 2013-06-07T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/rafarma-commences-antibiotic-ceftriaxone-production-070613/ 2013-06-07T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/mrn-presents-new-patient-recruitment-tool-mrn-rapid-100613/ 2013-06-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agilux-deploys-two-ab-sciex-triple-quad-6500-lc-msms-systems-100613/ 2013-06-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cytomx-pfizer-collaborate-on-probody-drug-conjugates-development-100613/ 2013-06-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-launches-new-developability-assessment-platform-for-clinical-safety-100613/ 2013-06-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-obtains-fda-priority-review-status-for-sofosbuvir-nda-100613/ 2013-06-10T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-market-and-distribute-belviq-weight-management-therapy-in-us-100613/ 2013-06-10T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/esperions-phase-2a-study-of-etc-1002-meets-primary-endpoint-100613/ 2013-06-10T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmavite-opens-new-manufacturing-facility-at-northeast-opelika-industrial-park-100613/ 2013-06-10T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/puma-biotechnology-commences-phase-iii-breast-cancer-trial-of-pb272-100613/ 2013-06-10T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-seeks-ema-approval-for-type-ii-variation-of-rienso-broad-ida-indication-100613/ 2013-06-10T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-agrees-to-acquire-pearl-therapeutics-for-115bn-100613/ 2013-06-10T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/country-life-recalls-1100-units-of-target-mins-iron-supplement-bottles-in-us-100613/ 2013-06-10T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharmaceuticals-receives-6m-payment-from-astrazeneca-100613/ 2013-06-10T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/iit-delhi-intends-to-set-up-new-pharmaceutical-technology-centre-110613/ 2013-06-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-rpif-announces-290m-funding-to-five-new-university-and-business-partnerships-110613/ 2013-06-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-neuroscience-selects-epharmasolutions-to-manage-clinical-trials-110613/ 2013-06-10T21:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-sanofi-pasteur-four-strain-influenza-vaccine-for-wide-age-range-110613/ 2013-06-11T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/jiangsu-chia-tai-tianqing-pharmaceutical-to-develop-biolinerxs-hepatitis-c-drug-110613/ 2013-06-11T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/stemline-therapeutics-sl-401-wins-orphan-drug-designation-from-fda-110613/ 2013-06-11T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/bionano-launches-irys-system-in-europe-for-genome-mapping-110613/ 2013-06-11T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-to-use-expres2ions-protein-production-technology-110613/ 2013-06-11T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/supernus-trokendi-xr-wins-tentative-fda-approval-for-epilepsy-110613/ 2013-06-11T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/xenon-acquires-exclusive-worldwide-license-to-isiss-antisense-drug-110613/ 2013-06-11T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-rolls-out-gas-chromatography-tandem-mass-spectrometer-110613/ 2013-06-11T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-pharma-receives-fda-approval-for-new-labeling-of-acetadote-110613/ 2013-06-11T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/questcor-pharmaceuticals-acquires-rights-from-novartis-to-develop-synacthen-120613/ 2013-06-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/obama-administration-decides-to-lift-age-restrictions-on-morning-after-pill-120613/ 2013-06-12T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lautech-receives-license-from-pcn-to-manufacture-drugs-120613/ 2013-06-12T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-pharma-to-expand-commercial-manufacturing-in-next-three-years-120613/ 2013-06-12T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/sobi-receives-fda-clearance-to-manufacture-kineret-in-austria-120613/ 2013-06-12T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/cobra-pharmaceuticals-to-re-launch-nutra-pharmas-cobroxin-pain-reliever-120613/ 2013-06-12T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-launches-pralia-subcutaneous-injection-60mg-syringe-120613/ 2013-06-12T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-clears-roches-polyarticular-juvenile-idiopathic-arthritis-drug-120613/ 2013-06-12T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biota-pharmaceuticals-commences-phase-2-trial-of-laninamivir-octanoate-120613/ 2013-06-12T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/rising-pharmaceuticals-to-launch-riluzole-50mg-tablets-120613/ 2013-06-12T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-presents-lc-ms-software-130613/ 2013-06-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/china-and-germanys-blue-inspection-body-partner-to-maintain-drug-quality-130613/ 2013-06-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-phase-iii-trinova-1-trial-of-recurrent-ovarian-cancer-drug-yields-positive-results-130613/ 2013-06-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dhl-launches-new-air-freight-service-for-pharmaceutical-products-and-medical-devices-130613/ 2013-06-13T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-revolade-receives-nice-approval-for-blood-disorder-treatment-130613/ 2013-06-13T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/walgreens-to-pay-80m-for-illegal-prescription-painkillers-distribution-settlement-130613/ 2013-06-13T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-in-215bn-settlement-with-teva-sun-pharma-over-protonix-patent-suit-130613/ 2013-06-13T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/bethel-recalls-weight-loss-pills-over-presence-of-unsafe-ingredients-130613/ 2013-06-13T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-jetrea-receives-nice-approval-for-eye-condition-treatment-130613/ 2013-06-13T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sci-launches-unit-dose-omega-3-packaging-130613/ 2013-06-13T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-introduces-tribrid-lc-ms-system-130613/ 2013-06-13T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/zealand-d-e-shaw-research-partner-to-develop-peptide-drug-140613/ 2013-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-simcere-join-hands-to-develop-orencia-in-china-140513/ 2013-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-enters-into-service-agreement-with-bd-biosciences-140613/ 2013-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/asis-riverview-facility-to-manufacture-ponatinib-api-140613/ 2013-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-pharma-to-expand-winchester-controlled-release-manufacturing-facility-140613/ 2013-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-xgeva-receives-fda-approval-to-treat-giant-cell-tumor-of-bone-140613/ 2013-06-14T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-partners-with-isomerase-therapeutics-to-develop-new-molecules-140613/ 2013-06-14T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/avantors-indian-facility-starts-cgmp-pharmaceutical-chemicals-production-140613/ 2013-06-14T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-jica-to-produce-measles-rubella-combined-vaccine-in-vietnam-140613/ 2013-06-14T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/addf-funds-madera-to-advance-development-of-small-molecule-drugs-140613/ 2013-06-14T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-active-biotech-reveal-phase-iia-study-results-of-oral-laquinimod-140613/ 2013-06-14T09:07:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-incyte-unveil-data-from-phase-2b-jada-study-of-baricitinib-140613/ 2013-06-14T09:08:00+00:00 https://www.pharmaceutical-business-review.com/news/prism-pharma-to-fund-trials-of-pri-724-with-15m-series-c-financing-140613/ 2013-06-14T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/synteracthcr-to-unveil-intelligent-clinical-development-platform-140613/ 2013-06-14T09:21:00+00:00 https://www.pharmaceutical-business-review.com/news/soviva-naturals-introduces-garcinia-cambogia-extract-for-weight-loss-170613/ 2013-06-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elona-biotechnologies-fails-to-open-production-facility-in-us-170613/ 2013-06-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-adc-partner-to-develop-new-antibody-drug-conjugate-to-treat-cancer-170613/ 2013-06-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-mhlw-clears-roches-avastin-as-glioblastoma-therapy-170613/ 2013-06-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-jakavi-demonstrates-overall-survival-of-myelofibrosis-patients-170613/ 2013-06-17T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/comentis-anvyl-to-form-alpharmagen-jv-for-nicotinic-modulators-170613/ 2013-06-17T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ambrx-partners-with-zhejiang-for-breast-cancer-antibody-drug-conjugate-development-170613/ 2013-06-17T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/amedra-re-launches-adrenaclick-to-treat-anaphylaxis-170613/ 2013-06-17T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-therapeuticsmds-ind-application-for-vaginal-estradiol-suppository-170613/ 2013-06-17T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-unveils-new-labeling-initiative-to-enhance-drug-safety-170613/ 2013-06-17T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ngm-astrazenecas-medimmune-partner-to-develop-diabetes-and-obesity-therapies-170613/ 2013-06-17T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/mendor-receives-ce-mark-clearance-for-its-diabetes-management-platform-180613/ 2013-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-invests-in-uk-hatfield-production-plant-to-create-new-facility-180613/ 2013-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roselabs-invests-6829m-to-establish-pre-filled-syringe-manufacturing-plant-180613/ 2013-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-unveils-dietary-supplement-label-database-180613/ 2013-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/puracap-selects-stayinfront-as-new-customer-relationship-management-partner-180613/ 2013-06-17T20:27:00+00:00 https://www.pharmaceutical-business-review.com/news/aop-orphan-to-spin-off-80-stake-in-activartis-180613/ 2013-06-18T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-buy-aragon-pharmaceuticals-for-1bn-180613/ 2013-06-18T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/labcorp-offers-roches-viral-load-assay-for-hepatitis-c-virus-180613/ 2013-06-18T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-wins-european-patent-for-influenza-virus-like-particles-in-plants-180613/ 2013-06-18T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharmaceutical-to-take-over-microdose-therapeutx-180613/ 2013-06-18T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-biotechnology-completes-patient-enrollment-in-ac-201-phase-ii-trial-180613/ 2013-06-18T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-announces-availability-of-type-2-diabetes-drugs-in-us-180613/ 2013-06-18T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-celgenes-revlimid-to-treat-myelodysplastic-syndromes-180613/ 2013-06-18T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/protalix-fiocruz-enter-into-supply-agreement-for-uplyso-190613/ 2013-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/brazil-plans-for-nationwide-production-of-h1n1-flu-vaccine-190613/ 2013-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pgi-to-invest-in-expanding-new-production-plant-in-china-190613/ 2013-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-dea-approves-amri-burlington-facility-to-handle-controlled-substances-190613/ 2013-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aspen-proposes-to-acquire-gsks-thrombosis-brands-and-ndb-site-190613/ 2013-06-19T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/apteka-naturel-launches-two-new-supplements-to-support-digestive-health-190613/ 2013-06-19T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/biogaia-purchases-outstanding-50-stake-of-twopac-190613/ 2013-06-19T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/civitas-wins-second-mjff-grant-to-advance-cvt-301-research-190613/ 2013-06-19T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-seeks-approval-for-oral-antiplatelet-agent-in-japan-190613/ 2013-06-19T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-exercises-rights-to-type-2-diabetes-drug-under-deal-with-transition-therapeutics-190613/ 2013-06-19T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/t3d-therapeutics-wins-exclusive-global-rights-to-db959-from-dara-biosciences-190613/ 2013-06-19T09:06:00+00:00 https://www.pharmaceutical-business-review.com/news/mapi-pharma-obtains-us-patent-for-tapentadol-analgesic-190613/ 2013-06-19T09:06:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-imposes-fine-on-ranbaxy-others-for-halting-generic-drugs-200613/ 2013-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxo-wellcome-uk-recalls-ventolin-syrup-bottles-due-to-glass-particle-risk-200613/ 2013-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-considers-sale-of-dermatology-portfolio-200613/ 2013-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lgc-genomics-covaris-join-hands-to-develop-ffpe-dna-extraction-solution-200613/ 2013-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chemocentryx-reaches-target-enrolment-in-phase-ii-trial-of-ccx140-200613/ 2013-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-astrazeneca-onglyza-diabetes-drug-fails-to-meet-superiority-objective-200613/ 2013-06-20T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ambrx-zhejiang-collaborate-on-breast-cancer-antibody-drug-conjugate-development-200613/ 2013-06-20T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-kissei-sue-sandoz-and-hetero-for-rapaflo-patent-infringement-200613/ 2013-06-20T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/kitasato-daiichi-seeks-approval-for-cell-culture-based-pandemic-influenza-vaccine-in-japan-200613/ 2013-06-20T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-bio-licenses-gostar-database-to-us-fda-for-drug-repositioning-200613/ 2013-06-20T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/oncosec-completes-enrollment-in-phase-ii-metastatic-melanoma-trial-of-immunopulse-200613/ 2013-06-20T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gsk-and-siemens-create-rd-consortium-with-astars-ices-200613/ 2013-06-20T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/tkl-research-constructs-new-clinical-research-plant-in-us-210613/ 2013-06-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-ribo-sign-license-agreement-to-develop-sirna-therapeutics-in-china-210613/ 2013-06-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/algeta-opens-xofigo-commercial-manufacturing-facility-in-norway-210613/ 2013-06-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-plans-to-reorganize-commercial-structure-in-europe-210613/ 2013-06-21T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-invests-eur175m-in-french-venture-for-rare-diseases-210613/ 2013-06-21T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/integrative-therapeutics-launches-nutritional-supplement-glycation-manager-210613/ 2013-06-21T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-places-purchase-orders-with-prometic-for-prion-capture-resin-210613/ 2013-06-21T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/bergenbio-begins-phase-1-trial-for-bgb324-to-treat-metastatic-cancers-210613/ 2013-06-21T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-secures-us-patent-for-cudc-907-dual-inhibitor-210613/ 2013-06-21T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-new-drug-application-for-durects-posidur-210613/ 2013-06-21T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/finesse-solutions-launches-new-bioreactors-for-rd-process-development-scale-up-210613/ 2013-06-21T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/raptors-procysbi-now-available-for-nephropathic-cystinosis-patients-in-us-210613/ 2013-06-21T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/greenphire-oracle-partner-to-automate-trial-planning-budgeting-and-payments-240613/ 2013-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-launches-nimbledesign-software-for-next-generation-sequencing-240613/ 2013-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-reveal-phase-iii-trial-data-of-empagliflozin-240613/ 2013-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-espha-launches-three-new-generic-medications-with-two-active-ingredients-240613/ 2013-06-24T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-commences-dosing-in-alx-076-phase-i-trial-to-treat-inflammatory-diseases-240613/ 2013-06-24T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/kannalife-sciences-biotech-sign-joint-venture-agreement-240613/ 2013-06-24T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-clears-theravance-vibativ-for-hospital-acquired-ventilator-associated-bacterial-pneumonia-240613/ 2013-06-24T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/mcm-labcorp-clinical-trials-enter-master-service-agreement-240613/ 2013-06-24T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-regains-rights-to-develop-azasite-xtra-in-north-america-240613/ 2013-06-24T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-teva-womens-health-plan-b-one-step-tablet-for-all-consumers-240613/ 2013-06-24T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-biologics-license-application-to-us-fda-for-vedolizumab-240613/ 2013-06-24T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-pfizer-snda-to-expand-xeljanz-labeling-240613/ 2013-06-24T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-presents-data-from-five-phase-iii-studies-of-albiglutide-to-treat-type-2-diabetes-250613/ 2013-06-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vivamab-adc-therapeutics-sign-license-deal-for-new-adc-to-treat-hematologic-cancers-250613/ 2013-06-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merge-launches-eclinical-os-marketplace-mobile-applications-250613/ 2013-06-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharmaceutical-introduces-generic-version-of-pfizers-viagra-in-europe-250613/ 2013-06-25T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-use-of-astellas-mycamine-for-injection-to-treat-pediatric-patients-250613/ 2013-06-25T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/virtify-rolls-out-new-clinical-content-management-platform-250613/ 2013-06-25T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/anthera-commences-phase-2-study-of-iga-nephropathy-therapy-250613/ 2013-06-25T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cromos-pharma-commences-operations-in-republic-of-belarus-250613/ 2013-06-25T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-temporarily-suspends-commercial-distribution-of-fycompa-in-germany-250613/ 2013-06-25T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-gdf-suez-boost-partnership-to-reduce-global-energy-footprint-250613/ 2013-06-25T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/alacrita-debiopharm-partner-to-identify-drug-candidates-from-massachusetts-life-science-cluster-250613/ 2013-06-25T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-cytokinetics-enter-into-research-agreement-for-skeletal-muscle-activators-260613/ 2013-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-contracts-basilea-to-develop-antibiotic-bal30072-260613/ 2013-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-bayer-healthcare-enter-new-antibody-drug-conjugate-collaboration-260613/ 2013-06-26T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-grants-marketing-approval-for-actavis-fibristal-to-treat-uterine-fibroids-260613/ 2013-06-26T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-begins-enrollment-in-phase-i-study-of-morab-066-260613/ 2013-06-26T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/itonis-seeks-fda-labeler-status-260613/ 2013-06-26T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-announces-us-patent-issuance-for-sialylation-technology-260613/ 2013-06-26T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/atheronova-begins-phase-1-trial-of-atherosclerosis-drug-candidate-260613/ 2013-06-26T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/miltenyi-obtains-license-to-manufacture-mb101-antobody-in-germany-260613/ 2013-06-26T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-rolls-out-new-aricept-dry-syrup-for-alzheimers-disease-treatment-in-japan-260613/ 2013-06-26T08:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-launches-studyview-to-boost-clinical-trials-operational-visibility-260613/ 2013-06-26T09:01:00+00:00 https://www.pharmaceutical-business-review.com/news/high-performance-nutrition-introduces-new-daily-nutritional-supplement-nr-260613/ 2013-06-26T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/arrayit-dhk-enter-distributorship-agreement-to-sell-genomic-tests-in-india-270613/ 2013-06-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-packaging-introduces-new-fhm-1000-series-laboratory-device-270613/ 2013-06-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-begin-enrollment-in-phase-ii-study-of-breast-cancer-drug-270613/ 2013-06-27T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-version-of-lamictal-xr-in-us-270613/ 2013-06-27T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-creates-new-immuno-oncology-platform-270613/ 2013-06-27T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/karo-bio-extends-autoimmune-disease-research-collaboration-with-pfizer-260613/ 2013-06-27T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/datapharm-introduces-dai-sys-to-unite-local-cros-for-international-clinical-trials-270613/ 2013-06-27T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-launches-amitiza-in-us-for-opioid-induced-constipation-270613/ 2013-06-27T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-new-workflow-option-for-cobas-hpv-test-receives-fda-approval-270613/ 2013-06-27T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sciclone-tlc-sign-licensing-agreement-for-proflow-270613/ 2013-06-27T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/lake-chemicals-readies-to-foray-into-us-and-eu-markets-with-four-cep-filings-270613/ 2013-06-27T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-cha-partner-to-develop-and-commercialize-plx-cells-in-south-korea-270613/ 2013-06-27T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-novartis-gsk-compete-to-acquire-elder-pharmas-domestic-formulations-operations-270613/ 2013-06-27T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-micronor-tablets-in-us-280613/ 2013-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/symphogen-obtains-milestone-payment-from-merck-under-sym004-research-deal-280613/ 2013-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-introduces-new-benchtop-mass-spectrometer-280613/ 2013-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mckesson-unveils-mobile-delivery-app-for-pharmacies-280613/ 2013-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/advance-research-associates-adopts-mednets-electronic-data-capture-system-280613/ 2013-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorm-prc-sign-mou-for-clinical-trial-management-in-us-280613/ 2013-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aspen-to-acquire-msds-api-manufacturing-business-products-for-1bn-280613/ 2013-06-28T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-eight-new-womens-care-products-in-india-280613/ 2013-06-28T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-pharma-obtains-us-patent-for-otrexu-injection-system-280613/ 2013-06-28T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/israeli-ministry-of-health-completes-gmp-audit-of-kamada-manufacturing-facility-280613/ 2013-06-28T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-opens-boston-innovation-center-280613/ 2013-06-28T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-grant-breakthrough-drug-status-to-glaxos-drisapersen-280613/ 2013-06-28T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-takes-over-pearl-therapeutics-010713/ 2013-07-01T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-latuda-as-monotherapy-adjunctive-therapy-for-bipolar-depression-010713/ 2013-07-01T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-lyxumia-cleared-for-type-2-diabetes-treatment-in-japan-010713/ 2013-07-01T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-johnson-johnson-innovation-mount-sinai-researchers-partner-for-ibd-research-010713/ 2013-07-01T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-and-agensys-to-co-develop-additional-adc-010713/ 2013-07-01T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocore-genentech-sign-strategic-alliance-to-develop-anti-cancer-biological-drugs-010713/ 2013-07-01T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-pfizer-report-positive-data-from-phase-iii-study-of-eliquis-010713/ 2013-07-01T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/toa-eiyo-receives-marketing-right-of-bisono-tape-in-japan-010713/ 2013-07-01T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cleanpath-to-launch-new-memory-enhancing-nutraceutical-010713/ 2013-07-01T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-recalls-benztropine-mesylate-injection-010713/ 2013-07-01T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-zyomyx-ink-distribution-agreement-for-cd4-test-in-hiv-care-010713/ 2013-07-01T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-obtains-positive-chmp-opinion-for-tafinlar-and-tyverb-010713/ 2013-07-01T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/blackstone-lion-capital-partner-to-bid-for-two-gsk-soft-drink-brands-020713/ 2013-07-02T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mmc-depot-adds-new-medical-containers-to-product-line-020613/ 2013-07-02T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-commercialize-verinata-healths-verifi-prenatal-test-in-israel-020713/ 2013-07-02T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/acebright-to-invest-1m-for-10-stake-in-nasvax-020713/ 2013-07-02T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-launches-new-alpha-26-sialyltransferase-enzyme-020713/ 2013-07-02T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-save-the-children-partner-to-identify-new-initiatives-for-reducing-child-deaths-020713/ 2013-07-02T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/soho-flordis-international-takes-over-ginsana-and-prothera-020713/ 2013-07-02T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioventus-purchases-exclusive-rights-to-pfizers-bmp-portfolio-020713/ 2013-07-02T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-begins-glpg1205-phase-i-study-for-inflammatory-disorders-020713/ 2013-07-02T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-onyx-seek-approval-for-nexavar-in-us-and-europe-020713/ 2013-07-02T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/new-genetic-test-for-breast-cancer-to-help-avoid-chemotherapy-020713/ 2013-07-02T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-selects-biologics-to-distribute-tarceva-020713/ 2013-07-02T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-provides-merck-with-access-to-fc-engineering-patent-030713/ 2013-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-acquires-binotal-in-latin-america-from-bayer-030713/ 2013-07-03T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/elder-pharmas-nutrahealth-buys-max-healthcare-in-uk-030713/ 2013-07-03T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/emory-university-expands-use-of-amcoms-secure-texting-app-030713/ 2013-07-03T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-extends-license-agreement-with-mitsubishi-tanabe-030713/ 2013-07-03T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/new-legislation-reduces-tax-for-us-renewable-chemical-producers-030713/ 2013-07-03T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-subcutaneous-herceptin-receives-chmps-positive-opinion-030713/ 2013-07-03T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-upgrades-handling-bottling-capabilities-in-eu-and-us-030713/ 2013-07-03T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-approves-in-use-shelf-life-extension-for-xaluprine-030713/ 2013-07-03T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-aurobindos-rizatriptan-benzoate-orally-disintegrating-tablets-030713/ 2013-07-03T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/pei-approves-emergent-to-market-biothrax-in-germany-030713/ 2013-07-03T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/protagen-sells-protein-services-unit-to-zukunftsfond-030713/ 2013-07-03T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxos-gsk744-and-jjs-tmc278-monthly-injection-therapy-may-control-hiv-040513/ 2013-07-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/idbs-vivenics-to-introduce-new-saas-approach-in-netherlands-pivot-park-040713/ 2013-07-03T21:48:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-launches-eno-digestive-antacid-in-tablet-liquid-forms-040713/ 2013-07-04T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/oliver-tolas-healthcare-packaging-announces-global-operations-expansion-040713/ 2013-07-04T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ssb-launches-sartocheck-4-plus-bag-tester-040713/ 2013-07-04T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/cipher-launches-epuris-acne-medication-in-canada-040713/ 2013-07-04T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-obtains-fda-priority-review-status-for-obinutuzumab-040713/ 2013-07-04T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mesa-buys-suretorque-product-line-of-bottle-cap-torque-testing-instruments-040713/ 2013-07-04T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-offers-new-metabolite-tests-for-mammalian-cell-fermentation-analytics-040713/ 2013-07-04T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sk-biopharmaceuticals-aribio-enter-strategic-alliance-to-develop-glaucoma-medication-040713/ 2013-07-04T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-novartis-consider-bidding-to-acquire-onyx-pharmaceuticals-040713/ 2013-07-04T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/tpi-prepares-to-open-qlf-pre-extraction-facility-for-inspection-by-sfda-040713/ 2013-07-04T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-stedim-biotech-introduces-smartphone-app-for-membrane-chromatography-050713/ 2013-07-04T21:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-orexos-zubsolv-as-opioid-dependence-maintenance-therapy-050713/ 2013-07-05T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/smile-brands-develops-web-app-for-dentists-050713/ 2013-07-05T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/toksoz-to-sell-turkish-generic-drug-maker-sanovel-050713/ 2013-07-05T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-therapeutics-enters-into-atm-equity-offering-sales-agreement-with-further-lane-securities-050713/ 2013-07-05T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ventirx-begins-active8-phase-ii-trial-of-small-molecule-toll-like-receptor-8-agonist-050713/ 2013-07-05T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-begins-two-additional-phase-i-studies-of-alx-0171-for-pediatric-development-050713/ 2013-07-05T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-optinose-partner-to-develop-breath-powered-intranasal-delivery-system-040713/ 2013-07-05T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/prana-obtains-hrec-approval-for-open-label-extension-study-in-alzheimers-disease-050713/ 2013-07-05T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-notice-of-patent-allowance-for-delmar-val-083-050713/ 2013-07-05T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/vwr-acquires-united-biochemicals-to-extend-life-science-capabilities-050713/ 2013-07-05T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/nanobiotix-secures-9m-funding-from-bpifrance-to-advance-nbtxr3-development-050713/ 2013-07-05T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/international-pharma-company-upgrades-to-cegedims-cloud-based-crm-solution-080713/ 2013-07-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tpg-considers-acquiring-envision-pharmaceutical-080713/ 2013-07-08T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-sobi-present-new-data-from-phase-iii-study-of-eloctate-for-hemophilia-a-080713/ 2013-07-08T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-initiates-new-ofatumumab-phase-iii-study-to-treat-pemphigus-vulgaris-080713/ 2013-07-08T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-reveals-initial-availability-of-qsymia-in-us-retail-pharmacies-080713/ 2013-07-08T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/new-dna-mapping-project-to-initially-focus-on-cancer-says-uk-health-secretary-080713/ 2013-07-08T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvents-partner-starts-phase-i-clinical-study-using-n-coder-antibody-080713/ 2013-07-08T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-pharma-bags-eur9m-grant-from-bpifrance-for-livatag-industrial-development-080713/ 2013-07-08T09:01:00+00:00 https://www.pharmaceutical-business-review.com/news/rafarma-pharm-inks-new-production-contract-for-para-aminosalicylic-acid-080713/ 2013-07-08T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/cha-biodiostech-files-ind-for-pluristems-plx-cells-with-kfda-080713/ 2013-07-08T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/prestige-brands-purchases-australian-otc-care-pharmaceuticals-090713/ 2013-07-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-lilly-and-boehringer-ingelheims-maa-for-new-insulin-glargine-product-090713/ 2013-07-09T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-therapeutics-granted-market-access-for-pixuvri-in-italy-090713/ 2013-07-09T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-receives-approval-for-lucentis-to-treat-myopic-choroidal-neovascularization-090713/ 2013-07-09T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-enters-into-license-and-supply-agreement-with-undisclosed-company-090713/ 2013-07-09T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-therapeutics-acquires-qutenza-and-np-1998-from-neurogesx-090713/ 2013-07-09T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocore-gsk-ink-research-and-licensing-agreement-to-discover-immtacs-090713/ 2013-07-09T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/xyngular-rolls-out-new-energy-booster-product-090713/ 2013-07-09T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/tri-anim-to-distribute-milestones-epidural-injection-technology-090713/ 2013-07-09T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/balanced-health-launches-endosterol-prostrate-therapy-to-treat-prostrate-problems-090713/ 2013-07-09T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/quigley-nutraceuticals-launches-tryptonite-dietary-sleep-supplement-in-us-090713/ 2013-07-09T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/forma-advances-tumor-metabolism-alliance-with-janssen-biotech-100713/ 2013-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-servier-collaborate-for-new-cardiovascular-treatment-options-100713/ 2013-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-renews-license-to-nextbio-research-platform-100713/ 2013-07-09T21:55:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-dow-sign-cellular-target-profiling-collaboration-100713/ 2013-07-10T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-seeks-fda-approval-for-metastatic-melanoma-combination-drug-100713/ 2013-07-10T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mayne-launches-doxycycline-hyclate-delayed-release-tablets-in-us-100713/ 2013-07-10T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmstandard-to-spin-off-otc-business-into-separate-entity-100713/ 2013-07-10T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/uniqure-and-chiesi-to-commercialize-glybera-co-develop-gene-therapy-for-hemophilia-b-100713/ 2013-07-10T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-bg-negev-partner-to-develop-anti-hepatitis-c-virus-antibodies-100713/ 2013-07-10T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/dipexium-obtains-new-us-patent-for-locilex-100713/ 2013-07-10T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/trimix-announces-availability-of-trimix-for-travel-at-krs-global-100713/ 2013-07-10T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/vetter-expands-its-portfolio-for-swfi-syringes-with-five-years-stability-data-100713/ 2013-07-10T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-obtains-access-to-antibody-program-from-wilex-110713/ 2013-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-selects-dotmatics-for-enterprise-informatics-solutions-110713/ 2013-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/accenture-launches-new-rd-service-to-pace-up-availability-of-new-drugs-to-market-110713/ 2013-07-11T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/karo-bio-chooses-reaxys-and-reaxys-medicinal-chemistry-110713/ 2013-07-11T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-obtains-european-approval-for-expanded-use-of-pneumococcal-vaccine-110713/ 2013-07-11T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/national-institute-for-health-research-taps-qlikview-to-boost-clinical-trial-progressions-110713/ 2013-07-11T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-terminates-aleglitazar-investigation-over-safety-issues-110713/ 2013-07-11T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/galen-to-market-and-sell-nuvos-synera-in-us-110713/ 2013-07-11T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/njm-packaging-presents-model-402-final-touch-print-apply-labeler-110713/ 2013-07-11T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/smoothie-king-launches-pure-recharge-smoothie-as-dietary-supplement-110713/ 2013-07-11T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-establishes-new-company-for-pharmaceutical-development-in-uk-110713/ 2013-07-11T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/tris-pharma-launches-generic-equivalent-of-procentra-in-us-110713/ 2013-07-11T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-fda-approval-for-use-of-ibrutinib-to-treat-two-b-cell-malignancies-110713/ 2013-07-11T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/almirall-launches-sativex-in-italy-110713/ 2013-07-11T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/serodus-signs-merger-agreement-with-phlogo-110713/ 2013-07-11T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/lifecodexxs-improved-prenatest-can-be-performed-at-early-stage-of-pregnancy-120713/ 2013-07-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-inject-130m-in-two-manufacturing-plants-in-ireland-120713/ 2013-07-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lotus-group-launches-new-supplement-manufacturing-unit-120713/ 2013-07-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-announces-availability-of-enzalutamide-prostate-cancer-medication-in-uk-120713/ 2013-07-12T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-supplemental-new-drug-application-for-bristol-myers-and-pfizers-eliquis-120713/ 2013-07-12T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/questcor-to-begin-pilot-commercialization-effort-for-hp-acthar-gel-120713/ 2013-07-12T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-executives-in-china-plead-guilty-to-bribery-and-tax-violations-120713/ 2013-07-12T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biodel-completes-dosing-in-phase-ii-trial-of-diabetes-drug-120713/ 2013-07-12T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-version-of-dacogen-in-us-120713/ 2013-07-12T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-sun-pharmaceuticals-generic-prandin-dibetes-drug-120713/ 2013-07-12T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-introduces-pharmasuite-v50-system-120713/ 2013-07-12T08:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ertelalsop-rolls-out-single-use-capsules-for-biopharmaceutical-uses-120713/ 2013-07-12T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-gilotrif-as-late-stage-non-small-cell-lung-cancer-therapy-150713/ 2013-07-15T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-withdraw-relvar-license-application-in-japan-150713/ 2013-07-15T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/luqa-signs-commercialization-deal-with-bmg-pharma-in-china-hong-kong-150713/ 2013-07-15T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-begins-patient-dosing-in-phase-ibii-proof-of-concept-study-of-v8144-150713/ 2013-07-15T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-mhra-recalled-16-drugs-made-at-wockhardts-waluj-site-in-india-150713/ 2013-07-15T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-biomedical-relocates-headquarters-to-cambridge-150713/ 2013-07-15T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/c2n-cambridge-isotope-laboratories-partner-to-commercialize-kinetic-biomarkers-150713/ 2013-07-15T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-pharma-plans-to-purchase-medicago-for-357m-150713/ 2013-07-15T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/indias-health-ministry-to-inspect-impact-of-pharma-fdi-policy-on-public-health-goals-150713/ 2013-07-15T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-wins-fda-approval-for-anda-of-generic-opana-er-150713/ 2013-07-15T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-signs-research-and-development-collaboration-with-harvard-medical-150713/ 2013-07-15T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/vh-nutrition-launches-new-testosterone-boosting-formula-testrush-150413/ 2013-07-15T08:53:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-profiles-opens-new-facility-in-england-160713/ 2013-07-16T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/roselabs-plans-to-raise-21m-to-expand-operational-facilites-160713/ 2013-07-16T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/vitality-health-wellness-introduces-natural-weight-loss-supplements-in-us-160713/ 2013-07-16T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-tofacitinib-rheumatoid-arthritis-drug-wins-more-international-approvals-160713/ 2013-07-16T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/purolite-codexis-partner-to-develop-immobilized-transaminase-enzymes-160713/ 2013-07-16T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-rejects-pfizers-bosutinib-cancer-drug-160713/ 2013-07-16T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-pharma-equipments-manufacturers-urge-dumping-duty-on-chinese-imports-160713/ 2013-07-16T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/eternity-pharmanova-collaborate-to-develop-new-branded-pharmaceuticals-160713/ 2013-07-16T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-actavis-anda-for-lamotrigine-orally-disintegrating-tablets-160713/ 2013-07-16T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/kush-bottles-launches-new-line-of-child-resistant-containers-to-store-medication-160713/ 2013-07-16T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-version-of-abbotts-trilipix-capsule-in-us-160713/ 2013-07-16T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/adc-therapeutics-enters-into-license-agreement-with-bzl-biologics-for-prostrate-cancer-170713/ 2013-07-17T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-biovitrum-join-hands-for-xiapex-in-eurasia-africa-170713/ 2013-07-17T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-enters-into-research-agreement-with-biosortia-170713/ 2013-07-17T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-completes-acquisition-of-cipla-medpro-south-africa-for-45643m-170713/ 2013-07-17T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-obtains-conditional-approval-of-erivedge-in-eu-170713/ 2013-07-17T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/medtronics-interventional-spine-division-to-promote-amgens-prolia-in-us-170713/ 2013-07-17T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/penn-pharma-invests-in-additional-specific-tablet-manufacturing-and-coating-capacity-170713/ 2013-07-17T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-gains-rights-to-asklepios-duplex-gene-therapy-vector-technology-170713/ 2013-07-17T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/rafarma-signs-imatinib-production-contract-with-jsc-f-synthesis-170713/ 2013-07-17T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorm-enters-into-deal-with-mayo-clinic-for-als-clinical-trial-and-nurown-manufacturing-300114-4168884/ 2014-01-30T09:20:00+00:00 https://www.pharmaceutical-business-review.com/news/xenetic-biosciences-agrees-to-restructure-licence-deal-with-baxter-310114-4169174/ 2014-01-31T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/optinose-says-new-drug-application-submitted-for-migraine-treatment-using-optinose-technology-310114-4169203/ 2014-01-31T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-adds-biotherapeutic-product-for-treatment-of-fibrosis-to-its-proprietary-product-pipeline-310114-4169223/ 2014-01-31T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-and-ema-agree-on-phase-iii-registration-study-for-treatment-of-colorectal-cancer-310114-4169321/ 2014-01-31T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/empiriko-and-creagen-biosciences-sign-partnership-agreement-310114-4169335/ 2014-01-31T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-dcri-form-collaborative-partnership-to-study-natural-history-of-ipf-310114-4169349/ 2014-01-31T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-rd-yale-school-of-medicine-sign-clinical-trial-data-sharing-agreement-310114-4169391/ 2014-01-31T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-astellas-to-end-phase-ii-breast-cancer-trial-of-tivozanib-310114-4169389/ 2014-01-31T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-biosciences-enters-into-pharmacy-supply-deal-with-raintree-310114-4169689/ 2014-01-31T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-releases-phase-iia-trial-of-ormd-0801-to-treat-type-2-diabetes-310114-4169703/ 2014-01-31T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-salixs-nda-filing-for-budesonide-foam-in-patients-with-distal-ulcerative-colitis-310114-4169744/ 2014-01-31T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/aerie-begins-phase-iib-trial-of-glaucoma-drug-pg324-310114-4169787/ 2014-01-31T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/vandas-hetlioz-gets-fda-approval-for-sleep-disorder-in-blind-people-030214-4169902/ 2014-02-02T23:02:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-to-consolidate-and-reorganize-research-and-development-divisions-030214-4170096/ 2014-02-03T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-files-lawsuit-against-several-companies-for-infringement-of-namenda-xr-patents-030214-4170105/ 2014-02-03T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-provides-statement-in-response-to-sanofi-us-lawsuit-030214-4170114/ 2014-02-03T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/regado-biosciences-announces-20m-private-placement-030214-4170137/ 2014-02-03T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/mmrglobal-receives-cancer-fighting-anti-cd20-monoclonal-antibodies-patent-in-korea-030214-4170198/ 2014-02-03T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-announces-continued-success-in-japanese-bridging-clinical-trials-030214-4170217/ 2014-02-03T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/psychogenics-receives-licenses-for-rtg4510-tauopathy-mouse-model-030214-4170260/ 2014-02-03T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/edisonpharma-enters-into-drug-development-agreement-with-dainippon-sumitomo-030214-4170436/ 2014-02-03T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-pharmaceuticals-gets-new-us-patent-for-ferumoxytol-030214-4170553/ 2014-02-03T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/techne-enters-into-distribution-agreement-with-fisher-scientific-030214-4170592/ 2014-02-03T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-completes-phase-iii-trial-program-for-treatment-of-hepatitis-c-genotype-1-030214-4170646/ 2014-02-03T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/eisais-phase-iii-trial-of-lenvatinib-meets-primary-endpoint-of-pfs-in-thyroid-cancer-patients-040214-4170706/ 2014-02-03T23:00:00+00:00 https://www.pharmaceutical-business-review.com/news/selcia-university-of-edinburgh-enter-gbp25m-project-for-new-fatal-disease-drug-040214-4170880/ 2014-02-04T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-therapeutics-receives-fda-approval-to-proceed-with-phase-ib-clinical-trial-in-metastatic-melanoma-040214-4171060/ 2014-02-04T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-to-use-cell-in-a-box-technology-to-develop-marijuana-based-cancer-treatments-040214-4171069/ 2014-02-04T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/ergomed-and-ferrer-to-develop-lorediplon-for-insomnia-040214-4171078/ 2014-02-04T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorm-receives-us-notice-of-allowance-for-its-stem-cell-technology-patent-040214-4171098/ 2014-02-04T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-trastuzumab-biosimilar-in-india-040214-4171154/ 2014-02-04T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-completes-acquisition-of-bristol-myers-squibbs-diabetes-business-040214-4171565/ 2014-02-04T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharma-launches-national-research-center-in-china-040214-4171581/ 2014-02-04T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-signs-cancer-immunotherapy-collaboration-licensing-agreement-with-merck-040214-4171495/ 2014-02-04T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/source-bioscience-opens-new-tramore-dna-sequencing-laboratory-in-ireland-040214-4171387/ 2014-02-04T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-pharmaceuticals-granted-fourth-rspo-lgr-pathway-patent-in-us-040214-4171045/ 2014-02-04T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-dkfz-extend-existing-alliance-to-develop-new-cancer-therapies-050214-4171730/ 2014-02-04T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/allstar-health-brands-announces-purchase-order-for-tapout-extreme-muscle-and-tapout-muscle-recovery-supplements-050214-4172084/ 2014-02-05T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/msc-nutrition-partners-with-wales-lions-captain-to-launch-its-advanced-sports-nutrition-brand-050214-4172090/ 2014-02-05T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-receives-complete-response-letter-from-fda-for-acute-migraines-drug-050214-4172097/ 2014-02-05T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/averica-discovery-services-enters-into-preferred-provider-agreement-with-irix-pharmaceuticals-050214-4172106/ 2014-02-05T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/hawaii-biotech-awarded-anthrax-anti-toxin-grant-by-niaid-050214-4172113/ 2014-02-05T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/great-lakes-neurotechnologies-secures-allowance-of-patent-for-controlling-parkinsons-therapy-in-response-to-symptoms-050214-4172128/ 2014-02-05T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-chattem-launches-otc-medicine-nasacort-allergy-24hr-nasal-spray-in-us-050214-4172210/ 2014-02-05T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-closes-patient-enrollment-in-phase-iii-trial-of-oxycodone-deterx-050214-4172478/ 2014-02-05T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/sosei-enters-into-deal-with-fujifilm-pharma-for-commercialization-of-loramyc-in-japan-050214-4172563/ 2014-02-05T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/bioventus-gets-assets-of-durolane-from-galderma-050214-4172565/ 2014-02-05T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-partners-with-amgen-incyte-and-pfizer-on-new-anti-cancer-regimens-with-mk-3475-060214-4172682/ 2014-02-05T23:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-announces-clinical-results-of-dysport-next-generation-in-cervical-dystonia-060214-4172890/ 2014-02-06T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/regulus-renews-strategic-alliance-with-sanofi-to-focus-on-orphan-disease-and-oncology-targets-060214-4172905/ 2014-02-06T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/innate-pharma-acquires-full-rights-to-anti-nkg2a-checkpoint-inhibitor-from-novo-nordisk-060214-4172916/ 2014-02-06T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-entering-into-a-master-clinical-trial-agreement-gru-cancer-center-060214-4172928/ 2014-02-06T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sonrgy-gets-license-from-uc-san-diego-to-commercialize-drug-delivery-nanotechnology-060214-4172910/ 2014-02-06T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patent-to-elorac-for-novel-acne-therapy-060214-4172935/ 2014-02-06T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/aegis-awarded-its-first-patent-for-oral-delivery-of-nucleotide-based-drugs-060214-4172952/ 2014-02-06T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-to-build-new-manufacturing-facility-in-singapore-060214-4173234/ 2014-02-06T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/av-therapeutics-davospharma-to-produce-chemotherapeutic-drug-capridine-060214-4173243/ 2014-02-06T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/audentes-genethon-to-develop-treatment-for-x-linked-myotubular-myopathy-060214-4173252/ 2014-02-06T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/kinex-pharma-pharmaessentia-enter-into-drug-licensing-deal-070214-4173354/ 2014-02-06T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/berry-consultants-acquires-100-interest-in-clinical-trial-simulation-software-070214-4173517/ 2014-02-07T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-engages-big-brand-media-for-brand-management-of-product-line-070214-4173527/ 2014-02-07T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/accelrys-announces-launch-of-sciencecloud-070214-4173554/ 2014-02-07T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/zytiga-now-reimbursed-in-quebec-for-use-prior-to-chemotherapy-in-men-with-metastatic-prostate-cancer-070214-4173563/ 2014-02-07T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-announces-interim-final-rule-to-produce-safe-infant-formula-that-supports-healthy-growth-070214-4173576/ 2014-02-07T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/baseline-measures-of-global-cra-workload-and-utilization-by-kenneth-a-getz-070214-4173580/ 2014-02-07T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/regimmune-initiates-patient-enrollment-in-phase-ii-trial-to-treat-graft-versus-host-disease-070214-4173725/ 2014-02-07T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-biopharma-submits-phase-ii-study-protocol-for-liver-cancer-drug-070214-4173600/ 2014-02-07T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrums-cancer-drug-beleodaq-gets-fda-priority-review-070214-4173700/ 2014-02-07T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-enters-into-16m-vaccine-development-deal-with-new-client-070214-4174068/ 2014-02-07T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/trigemina-expands-phase-ii-trial-of-ti-001-for-chronic-migraine-070214-4174110/ 2014-02-07T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/alcobra-files-ind-application-for-extended-release-metadoxine-to-treat-adhd-patients-100214-4174301/ 2014-02-09T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-files-for-us-approval-of-ledipasvirsofosbuvir-fixed-dose-combination-tablet-for-genotype-1-hepatitis-c-100214-4176973/ 2014-02-10T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/targovax-releases-promising-phase-i-trial-results-of-tg01-immunotherapy-100214-4175096/ 2014-02-10T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ahf-mco-awarded-ahca-managed-medical-assistance-contract-to-serve-broward-miami-dade-monroe-county-hivaids-patients-100214-4174544/ 2014-02-10T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/easton-signs-letter-of-intent-nda-enters-into-negotiations-with-private-bc-company-100214-4174558/ 2014-02-10T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/puma-biotechnology-announces-positive-outcome-of-european-opposition-proceedings-100214-4174562/ 2014-02-10T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/covis-announces-new-expanded-dosage-options-of-lanoxin-for-cardiac-patients-with-mild-to-moderate-heart-failure-100214-4174567/ 2014-02-10T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-releases-positive-top-line-results-from-phase-iii-trial-prostate-cancer-drug-decapeptyl-100214-4174662/ 2014-02-10T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-to-launch-diego-pellicer-gold-branded-cannabinoid-extracts-100214-4175033/ 2014-02-10T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/lifesci-advisors-initiates-coverage-of-cynapsus-therapeutics-100214-4174577/ 2014-02-10T10:32:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerions-juxtapid-capsules-secure-canadian-approval-for-hofh-treatment-110214-4175220/ 2014-02-11T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-expects-to-continue-success-of-cell-in-a-box-technology-with-marijuana-based-treatments-110214-4175388/ 2014-02-11T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biolight-announces-start-of-clinical-study-with-diagnostear-dry-eye-syndrome-diagnostic-assay-110214-4175302/ 2014-02-11T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/aits-phase-ii-clinical-trial-for-cystic-fibrosis-adds-schneider-childrens-medical-center-of-israel-as-second-site-in-expanded-trial-110214-4175364/ 2014-02-11T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/broadview-ventures-invests-in-novel-stroke-drug-company-remedy-pharmaceuticals-110214-4175348/ 2014-02-11T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fluxion-expands-isoflux-discovery-services-capabilities-with-clinical-sample-procurement-110214-4175379/ 2014-02-11T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/neuro-biotech-performs-reverse-merger-with-institute-of-biomedical-research-110214-4175399/ 2014-02-11T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-files-phase-iia-protocol-to-fda-to-treat-patients-with-type-1-diabetes-110214-4175589/ 2014-02-11T09:42:00+00:00 https://www.pharmaceutical-business-review.com/news/iteos-therapeutics-submits-patent-for-immunomodulators-in-cancer-immunotherapy-110214-4175592/ 2014-02-11T09:42:00+00:00 https://www.pharmaceutical-business-review.com/news/scottish-medicines-consortium-accepts-psividas-iluvien-to-treat-dme-110214-4175594/ 2014-02-11T09:43:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-seeks-approval-of-additional-indication-for-mogamulizumab-in-japan-110214-4175600/ 2014-02-11T09:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-regeneron-release-two-year-results-from-phase-iii-trial-of-vegf-trap-eye-110214-4175602/ 2014-02-11T09:43:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-selects-naglu-fusion-protein-drug-candidate-bmn-250-to-treat-sanfilippo-b-syndrome-120214-4175652/ 2014-02-11T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ovascience-gets-two-us-patents-covering-augment-fertility-treatment-120214-4178643/ 2014-02-11T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/diavacs-announces-a-strategic-collaboration-with-profil-institute-for-for-type-1-diabetes-therapy-120214-4178660/ 2014-02-12T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/vitatech-nutritional-launches-body-soul-nutritional-supplements-120214-4176038/ 2014-02-12T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/targeted-medical-completes-promotion-and-distribution-agreement-for-clearwayz-120214-4176087/ 2014-02-12T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-signs-agreement-to-market-sugardown-in-us-120214-4176107/ 2014-02-12T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/trovita-health-science-introduces-new-high-protein-nutritional-shake-enu-120214-4176333/ 2014-02-12T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medifast-announces-partnership-with-the-v-foundation-for-cancer-research-120214-4176156/ 2014-02-12T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/synco-to-manufacture-advaxis-new-drug-candidate-adxs-hpv-120214-4176540/ 2014-02-12T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-gets-exclusive-rights-to-cynviloq-in-australia-canada-and-mexico-120214-4176542/ 2014-02-12T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-samsung-bioepis-to-develop-insulin-glargine-candidate-for-diabetes-120214-4176546/ 2014-02-12T08:56:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-announces-us-commercial-availability-of-versacloz-oral-suspension-120214-4176167/ 2014-02-12T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-to-acquire-affiniums-antibiotic-clinical-assets-platform-for-new-antibiotics-120214-4176181/ 2014-02-12T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ganymeds-imab027-enters-phase-iii-trial-to-treat-ovarian-cancer-130214-4176626/ 2014-02-12T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/celgenes-myeloma-drug-pomalyst-approved-in-canada-130214-4176757/ 2014-02-13T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-pharmaceuticals-announces-filing-for-marketing-authorization-of-belviq-in-brazil-130214-4176991/ 2014-02-13T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/sprout-pharmaceuticals-receives-clear-guidance-from-fda-on-path-forward-to-resubmit-nda-for-flibanserin-130214-4176996/ 2014-02-13T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/altos-therapeutics-receives-allowance-for-issue-of-us-patent-130214-4177016/ 2014-02-13T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-announces-expansion-of-tapout-branded-product-with-launch-of-muscle-explosion-130214-4177051/ 2014-02-13T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-announces-positive-preclinical-results-for-novel-treatment-for-chronic-myeloid-leukemia-130214-4177097/ 2014-02-13T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-and-ucsf-enter-into-collaboration-for-catalyst-awards-program-130214-4177219/ 2014-02-13T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pyxant-to-provide-laboratory-services-for-dcrs-early-clinical-trials-130214-4177522/ 2014-02-13T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-for-durects-anaesthetic-drug-posidur-130214-4177526/ 2014-02-13T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/phosphate-to-manage-clinipaces-phase-ii-trial-of-pt20-to-treat-hyperphosphataemia-130214-4177528/ 2014-02-13T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/agenus-acquires-swiss-biopharmaceutical-firm-4-antibody-140214-4177763/ 2014-02-14T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pronutria-announces-launch-of-two-clinical-trials-140214-4178733/ 2014-02-14T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/prothelia-and-university-of-nevada-enter-into-strategic-agreements-with-alexion-for-neuromuscular-disorder-140214-4177995/ 2014-02-14T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-licenses-epigenetic-drug-discovery-program-to-bayer-pharma-140214-4178025/ 2014-02-14T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-announces-publication-of-results-from-phase-iii-study-of-zohydro-er-extended-release-capsules-140214-4178033/ 2014-02-14T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-announces-positive-preliminary-biochemical-findings-from-synovial-fluid-of-knees-treated-in-spring-study-140214-4178037/ 2014-02-14T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-announces-launch-of-pariet-triple-formulation-combination-packs-in-japan-140214-4178043/ 2014-02-14T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-lundbecks-schizophrenia-drug-abilify-maintena-approved-in-canada-140214-4177946/ 2014-02-14T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-obtains-full-approval-from-fda-for-chronic-myeloid-leukemia-drug-140214-4178095/ 2014-02-14T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/infectex-enters-into-license-deal-with-qurient-for-q203-140214-4178312/ 2014-02-14T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/aurigene-pierre-fabre-enter-into-licensing-deal-for-new-cancer-therapeutic-in-immuno-oncology-140214-4178316/ 2014-02-14T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-starts-phase-lll-trial-of-mepolizumab-in-egpa-patients-170214-4178508/ 2014-02-16T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-gets-positive-opinion-on-european-orphan-drug-status-for-isis-ttr-rx-170214-4178964/ 2014-02-17T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/agila-specialties-initiates-voluntary-nationwide-recall-of-10-lots-of-etomidate-injection-170214-4178677/ 2014-02-17T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/enzymatics-launches-archer-targeted-sequencing-technology-170214-4178687/ 2014-02-17T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-to-discontinue-namenda-tablets-170214-4178696/ 2014-02-17T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/medifirst-solutions-completes-acquisition-for-remote-technical-support-company-170214-4178705/ 2014-02-17T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ben-venue-laboratories-issues-voluntary-recall-of-acetylcysteine-solution-170214-4178766/ 2014-02-17T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-gets-fda-approval-to-produce-vpriv-drug-substance-at-massachusetts-facility-170214-4178915/ 2014-02-17T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/menarini-to-market-sell-moberg-kerasal-nail-in-south-east-asia-170214-4178949/ 2014-02-17T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-astellas-end-deal-to-develop-cancer-drug-tivozanib-170214-4178955/ 2014-02-17T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-completes-enrollment-in-phase-ii-trial-of-glpg0974-to-treat-ulcerative-colitis-180214-4179026/ 2014-02-17T23:18:00+00:00 https://www.pharmaceutical-business-review.com/news/dbv-technologies-and-mount-sinai-hospital-enter-into-research-collaboration-for-crohns-disease-180214-4180245/ 2014-02-18T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-pharmaceuticals-announces-publication-of-mugard-study-data-180214-4180259/ 2014-02-18T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/qu-biologics-opens-crohns-disease-clinical-trial-to-us-participants-180214-4180272/ 2014-02-18T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/walgreens-expands-access-to-pharmacist-led-hepatitis-c-care-as-treatments-advance-180214-4179293/ 2014-02-18T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/chindex-to-be-acquired-by-tpg-and-fosun-pharma-180214-4179302/ 2014-02-18T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/california-stem-cell-announces-fda-approval-of-phase-ii-cancer-stem-cell-clinical-trial-for-ovarian-cancer-180214-4180279/ 2014-02-18T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-to-provide-sirions-shrna-development-services-180214-4179693/ 2014-02-18T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-announces-acquisition-of-costim-pharmaceuticals-180214-4179543/ 2014-02-18T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-acquires-macau-based-healthcare-distributor-glory-180214-4179586/ 2014-02-18T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-servier-to-develop-new-products-candidatesto-treat-solid-tumors-180214-4179657/ 2014-02-18T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-starts-new-phase-iii-rivaroxaban-trial-180214-4179837/ 2014-02-18T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/prana-releases-positive-results-of-phase-ii-huntington-disease-trial-190214-4179902/ 2014-02-18T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-announces-positive-results-from-protect-viii-trial-190214-4180190/ 2014-02-19T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-announces-launch-of-us-tapout-sales-190214-4180198/ 2014-02-19T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-receives-key-3d-cell-expansion-patent-in-australia-190214-4180205/ 2014-02-19T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/mapi-pharma-granted-us-patent-covering-process-for-preparation-of-fingolimod-for-multiple-sclerosis-180214-4180251/ 2014-02-19T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-pharma-announces-strengthening-and-extension-of-industrial-protection-of-livatag-until-2031-190214-4180341/ 2014-02-19T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/microbiome-therapeutics-announces-clinical-trial-results-for-type-2-diabetes-drug-190214-4180408/ 2014-02-19T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-cheplapharm-sign-new-regional-agreement-190214-4180699/ 2014-02-19T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cytovance-pamlico-sign-development-and-cgmp-manufacturing-agreement-190214-4180704/ 2014-02-19T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-chelsea-northera-to-treat-noh-patients-190214-4180712/ 2014-02-19T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-releases-positive-results-of-phase-ii-trial-of-bcc-drug-sonidegib-200214-4180809/ 2014-02-19T23:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-announces-update-in-commercialization-partnership-for-brinavess-in-select-european-markets-200214-4181048/ 2014-02-20T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/mhi-announces-launch-of-arteria-program-200214-4181086/ 2014-02-20T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/tauriga-sciences-signs-mou-to-acquire-california-based-manufacturer-of-topical-and-medicinal-cannabis-products-200214-4181092/ 2014-02-20T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/parcell-laboratories-partners-with-upmc-to-study-effective-stem-cell-based-wrinkle-treatments-200214-4181096/ 2014-02-20T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/oculus-receives-approval-for-oral-and-throat-infection-products-in-mexico-200214-4181103/ 2014-02-20T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/mesoblast-gets-european-patent-for-mesenchymal-precursor-cells-in-cardiac-and-vascular-conditions-200214-4181141/ 2014-02-20T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-companys-oritavancin-nda-accepted-by-fda-200214-4181432/ 2014-02-20T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-negotiates-1m-financing-for-progression-of-products-and-start-of-observational-trials-200214-4181938/ 2014-02-20T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-doses-first-patient-in-second-phase-ii-trial-of-oms824-200214-4181407/ 2014-02-20T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-biosys-expands-drug-discovery-deal-with-janssen-pharmaceutica-200214-4181454/ 2014-02-20T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biomotiv-to-develop-bioatlas-th22-pathway-directed-antibody-for-ibd-oncologic-indications-200214-4181475/ 2014-02-20T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/curx-pharma-enters-into-license-deal-with-gilead-sciences-202014-4181480/ 2014-02-20T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-starts-phase-iii-regorafenib-trial-in-crc-patients-with-resected-liver-metastases-210214-4181573/ 2014-02-20T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/revive-therapeutics-signs-material-transfer-agreement-with-japanese-pharmaceutical-company-210214-4182653/ 2014-02-21T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/chemical-abstracts-service-and-astrazeneca-agree-to-five-year-scifinder-contract-210214-4182660/ 2014-02-21T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/john-a-moran-eye-centers-voyant-biotherapeutics-enters-into-exclusive-rd-collaboration-agreement-with-allergan-210214-4181886/ 2014-02-21T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-receives-notice-of-allowance-for-patent-claims-covering-modified-pectin-for-treatment-of-chronic-inflammation-200214-4181962/ 2014-02-21T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/mccarthy-completes-construction-of-j-craig-venter-institutes-landmark-net-zero-energy-genomic-laboratory-in-la-jolla-210214-4181935/ 2014-02-21T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/childrens-hospital-los-angeles-awarded-17-million-by-nih-to-fund-clinical-research-on-hivaids-210214-4181912/ 2014-02-21T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/first-patient-enrolled-in-phase-iii-of-compact-a-study-of-volume-reduced-subcutaneous-c1-inh-for-prevention-of-hereditary-angioedema-attacks-210214-4181954/ 2014-02-21T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-files-orphan-drug-application-to-us-fda-for-preeclampsia-210214-4182176/ 2014-02-21T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-charituniversittsmedizin-berlin-to-expand-clinical-research-in-germany-210214-4182166/ 2014-02-21T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/prima-neopharm-finalize-license-deal-to-market-cvac-in-israel-and-palestine-210214-4182237/ 2014-02-21T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-gets-positive-opinion-from-emas-chmp-for-morquio-a-syndrome-drug-vimizim-210214-4182250/ 2014-02-21T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-files-elvanse-for-an-adult-licence-in-the-uk-denmark-and-sweden-210214-4182320/ 2014-02-21T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-gets-fda-approval-for-kalydeco-snda-240214-4182411/ 2014-02-23T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gc-aesthetics-raises-60m-to-fund-global-growth-and-new-product-development-240214-4182754/ 2014-02-24T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/self-regional-healthcare-clemson-greenwood-genetic-center-partnership-creates-national-hub-for-human-genetics-research-240214-4182763/ 2014-02-24T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/amarin-announces-fda-award-of-three-year-exclusivity-for-vascepa-capsules-240214-4182771/ 2014-02-24T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-medical-receives-japanese-patent-issuance-for-triferic-gmp-formulation-240214-4182775/ 2014-02-24T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordics-mva-bn-vaccine-platform-selected-by-us-dod-for-new-vaccine-development-240214-4182781/ 2014-02-24T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-marketing-authorization-for-janssen-cilags-type-2-diabetes-mellitus-drug-240214-4182855/ 2014-02-24T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-introduces-premature-ejaculation-drug-ejectdelay-in-us-240214-4183187/ 2014-02-24T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-genentechs-dme-drug-lucentis-gets-approval-in-japan-240214-4183160/ 2014-02-24T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/scynexis-antifungal-agent-scy-078-gets-fda-qidp-designation-240214-4183275/ 2014-02-24T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/tevas-duoresp-spiromax-gets-positive-chmp-opinion-to-treat-asthma-and-copd-240214-4183249/ 2014-02-24T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-gets-fda-breakthrough-designation-for-daclatasvir-based-regimen-250214-4183423/ 2014-02-24T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/revo-biologics-announces-submission-of-ind-for-atryn-in-preeclampsia-250214-4184933/ 2014-02-25T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/junction-solutions-to-implement-microsoft-dynamics-ax-at-array-biopharma-250214-4183840/ 2014-02-25T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-announces-approval-for-additional-indication-of-regpara-tablets-250214-4183848/ 2014-02-25T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-pharmaceuticals-announces-european-commissions-orphan-drug-designation-to-soliris-250214-4183849/ 2014-02-25T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/response-scientific-prepares-microvail-micronutrients-for-release-into-market-250214-4183855/ 2014-02-25T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cha-announces-new-program-to-accelerate-innovation-in-life-sciences-and-health-care-250214-4183893/ 2014-02-25T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/metabolon-patia-biopharma-enter-into-agreement-for-quantose-ir-prediabetes-test-in-mexico-250214-4183952/ 2014-02-25T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-review-of-salix-pharmings-hae-drug-ruconest-to-july-250214-4184191/ 2014-02-25T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ardelyx-licenses-nap2b-phosphate-inhibitor-program-to-sanofi-for-198m-250214-4184326/ 2014-02-25T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/primco-canmed-to-build-new-joint-medical-marijuana-production-facility-in-canada-250214-4184359/ 2014-02-25T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-regenerons-eylea-injection-sbla-for-new-eye-treatment-250214-4184396/ 2014-02-25T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/xoma-gets-fda-orphan-drug-status-for-treatment-of-pyoderma-gangrenosum-250214-4184409/ 2014-02-26T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-myalept-gets-fda-approval-for-treatment-of-rare-metabolic-disease-260214-4184586/ 2014-02-26T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-continues-to-expand-regional-partnership-with-henkel-in-asia-260214-4184913/ 2014-02-26T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-launches-exclusive-partnership-and-sales-distribution-agreement-with-muscle-maker-grill-260214-4184922/ 2014-02-26T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-granted-patent-on-the-manufacturing-of-cf101-in-japan-260214-4184939/ 2014-02-26T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/kadmon-announces-co-promotion-agreement-with-valeant-pharmaceuticals-for-syprine-capsules260214-4184949/ 2014-02-26T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-receives-us-patent-for-xartemis-xr-260214-4184953/ 2014-02-26T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/healthy-directions-announces-launch-of-krill-omega-defense-260214-4184978/ 2014-02-26T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pmv-pharma-chiromics-to-develop-new-cancer-and-infectious-disease-therapeutics-260214-4185336/ 2014-02-26T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/anikas-osteoarthritis-drug-monovisc-gets-fda-approval-260214-4185303/ 2014-02-26T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/verastem-secures-rights-to-cancer-stem-cell-inhibitor-vs-4718-from-poniard-pharma-260214-4185368/ 2014-02-26T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/humanetics-to-develop-new-drugs-for-us-army-to-treat-phosgene-exposure-260214-4185457/ 2014-02-26T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/altheus-completes-dosing-patients-in-phase-ii-trial-of-zoenasa-to-treat-ulcerative-colitis-270214-4185574/ 2014-02-26T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mpi-research-invicro-and-3d-imaging-to-open-new-imaging-center-in-may-270214-4185828/ 2014-02-27T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-to-standardize-on-veeva-systems-cloud-based-cms-to-increase-organizational-agility-270214-4186626/ 2014-02-27T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-extends-patent-life-on-therapeutic-antibodies-270214-4185923/ 2014-02-27T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-therapeutics-secures-us-patent-for-galectin-inhibitor-in-fatty-liver-disease-270214-4185945/ 2014-02-27T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/rosetta-genomics-to-receive-us-patent-for-oncology-therapeutic-270214-4185966/ 2014-02-27T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/noble-biomaterials-calls-for-research-proposals-for-x-static-antimicrobial-technology-270214-4185974/ 2014-02-27T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/intelgenx-announces-receipt-of-two-additional-us-patent-allowances-related-to-proprietary-technology-270214-4185983/ 2014-02-27T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/empiriko-interchim-enter-into-agreement-to-accelerate-drug-discovery-270214-4186039/ 2014-02-27T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/santalis-enters-into-license-deal-to-commercialize-otc-dermatology-products-270214-4186345/ 2014-02-27T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/viroxis-to-commercialize-otc-sandalwood-oil-containing-dermatology-product-270214-4186397/ 2014-02-27T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/g3-caprion-to-identify-cardiovascular-disease-biomarkers-and-drug-targets-270214-4186413/ 2014-02-27T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-to-acquire-chinese-otc-drug-maker-dihon-280214-4186537/ 2014-02-27T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/mast-therapeutics-completes-acquisition-of-aires-pharmaceuticals-280214-4186768/ 2014-02-28T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-announces-extension-of-contract-with-hhs-barda-280214-4186785/ 2014-02-28T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-signs-agreement-with-osmotica-pharmaceutical-to-promote-khedezla-tablets-280214-4186799/ 2014-02-28T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-therapeutics-announces-initiation-of-phase-i-study-of-selinexor-in-singapore-280214-4186877/ 2014-02-28T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cel-sci-reports-146-patients-enrolled-in-phase-iii-immunotherapy-head-and-neck-cancer-trial-280214-4186886/ 2014-02-28T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-submits-ind-application-to-fda-for-oral-tyrosine-kinase-inhibitor-280214-4186953/ 2014-02-28T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-redhill-enter-license-agreement-for-solid-bowel-prep-product-rhb-106-28214-4187097/ 2014-02-28T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-mucormycosis-drug-isavuconazole-gets-fda-qidp-designation-280214-4187281/ 2014-02-28T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-licenses-gw-technology-for-new-hrs-compound-ljpc-501-280214-4187254/ 2014-02-28T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/allergen-starts-phase-iib-clinical-trial-for-peanut-allergy-oral-immunotherapy-280214-4187335/ 2014-02-28T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/genscript-launches-genplus-next-generation-gene-synthesis-technology-280214-4186757/ 2014-02-28T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-files-nda-for-tak-438-in-japan-to-treat-acid-related-diseases-030314-4187572/ 2014-03-02T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-pharmaceutical-signs-five-year-extension-of-mou-with-south-korea-ministry-of-health-and-welfare-030314-4187838/ 2014-03-03T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-and-transition-therapeutics-modify-development-and-commercialization-rights-of-elnd005-program-030314-4187864/ 2014-03-03T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biotie-in-advanced-discussions-for-partnership-for-further-development-of-syn120-030314-4187874/ 2014-03-03T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinion-for-tablet-formulation-of-mercks-noxafil-030314-4187936/ 2014-03-03T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-secures-exclusive-rights-to-commercialize-isavuconazole-in-us-and-canada-030314-4188266/ 2014-03-03T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/mei-pharmas-leukemia-drug-pracinostat-gets-fda-orphan-status-030314-4188345/ 2014-03-03T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-supports-european-patient-charter-on-idiopathic-pulmonary-fibrosis-030314-4187960/ 2014-03-03T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-to-start-construction-of-new-ik8-research-building-at-fuji-research-park-030314-4188273/ 2014-03-03T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-biopharma-gets-patent-acceptance-in-australia-for-neuvax-030314-4188288/ 2014-03-03T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-starts-phase-iii-breast-cancer-trial-of-eribulin-mesylate-versus-paclitaxel-030314-4188358/ 2014-03-03T07:45:00+00:00